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CHAPTER 1

INTRODUCTION

This chapter has been published as: How to get extra performance from a
chromosome: recognition and modification of the X chromosome in male
Drosophila melanogaster. Kong Y. and Meller V.H. (2007) The Encyclopedia of
Genetics, Genomics, Proteomics and Bioinformatics. Part I Genetics. Section 1.3
Epigenetics. It is reproduced here with updates that reflect recently published
material.

Differentiated sex chromosomes cause genetic imbalance
Many organisms have a single X chromosome in males and two in
females. The X chromosome is gene-rich and carries genes required in both
sexes. By contrast, the Y is often gene-poor, and may carry genes only required
in males. The resulting imbalance in the dosage of X-linked genes is fatal if not
addressed early in life. Equalization of expression between the sexes is an
essential feature of differentiation in flies, ma mmals, and the wor m
Caenorhabditis elegans. Although the problem is common, the strategy used to
solve it in each of these organisms is distinct (Figure 1-1). To equalize
expression between C. elegans males (XO; one X chromosome but no Y
chromosome) and XX hermaphrodites, hermaphrodites reduce transcription from
both X chromosomes by 50%. Mammalian females silence most genes on a
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Figure 1-1. Organisms use divergent strategies to compensate sex
chromosome gene dosage. (A) C. elegans hermaphrodites (right) have 2 X
chromosomes, whereas males have a single X chromosome and no Y
chromosome (left). Association of the repressive DCC complex reduces
expression of both hermaphrodite X chromosomes by about 50%. (B)
Mammalian females (right) randomly silence a single X chromosome. The
remaining active X chromosome is transcriptionally equivalent to the single X
chromosome of males. (C) Drosophila males increase expression from their X
chromosome by modulation of chromatin structure (left). Female X chromosomes
remain unchanged.
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single X chromosome. The remaining X chromosome is transcriptionally
equivalent to the single X chromosome of males. By contrast, Drosophila males
increase expression from their single X chromosome about two fold. Although
these methods for equalizing expression are overtly very different, each
organism regulates the X chromosome through modulation of chromatin
architecture.
These animals must accurately and selectively modulate a single
chromosome or a pair of chromosomes in one sex. Interestingly, both mammals
and flies use large noncoding RNAs to direct chromatin-modifying proteins that
regulate expression. The large Xist (X inactive specific transcript) is transcribed
from and directs silencing to the inactive X chromosome of mammalian females
(reviewed by (Plath et al., 2002). As silencing of both X chromosomes would be
lethal, this process is restricted to chromatin in cis to a single Xist allele.
Drosophila males have two large, noncoding transcripts, roX1 (RNA on the X1),
and roX2 (RNA on the X2), that are necessary for localization of a complex of
proteins and roX RNA to the male X chromosome (Meller and Rattner, 2002). In
both mammals and flies, this process likely involves two steps: recruitment of a
protein complex, followed by modulation of gene expression. This review will
focus on advances in understanding the process of recognition and modulation in
flies. It will center on the role of the roX transcripts in recognition and modification
of the X chromosome.
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RNA and protein coat the X chromosome of Drosophila males
Many of the genes necessary for dosage compensation in flies were
identified through male-specific lethal (msl) mutations. These genes, maleless
(mle), the male-specific lethals 1, 2, and 3 (msl1, 2, and 3), and males absent on
first (mof), are collectively known as the male-specific lethals (reviewed by
(Mendjan and Akhtar, 2007). Mutations in these genes cause developmental
delay and lethality in males, but are not essential in females. The genes that
encode the roX RNAs are X-linked and functionally redundant for dosage
compensation. Both properties make them unlikely to be identified by
conventional mutagenesis and phenotypic analysis. Accordingly, the roX genes
were discovered serendipitously (Amrein and Axel, 1997; Meller et al., 1997).
Immunolocalization of MSL proteins or in situ hybridization to roX on polytene
preparations reveals finely banded enrichment along the X chromosome (Figure
1-2). The MSL proteins and roX RNA coimmunoprecipitate, demonstrating that
they form a complex (Meller et al., 2000; Smith et al., 2000). Removal of
individual members of the complex disrupts its localization and can reduce the
stability of remaining molecules. This is particularly dramatic for the roX RNAs,
which are unstable upon elimination of any MSL protein (Amrein and Axel, 1997;
Meller et al., 1997). Mutation of mle, msl3, or mof reduces X-chromosome
binding by remaining members of the complex, but a subset of sites able to bind
the remaining proteins is retained on the X chromosome. The most prominent of
these sites are the roX genes themselves (reviewed by (Kelley, 2004). MSL1 and
MSL2 have a more central role in regulation and assembly of the MSL complex
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Figure 1-2. MSL proteins and roX RNA form a complex that binds to the
Drosophila X chromosome. (A) Immunodetection of MSL2 on a polytene
chromosome preparation from a male larva. The X chromosome binds MSL2,
detected with Texas Red. DNA appears blue. (B) Molecular interactions between
MSL proteins and RNA. Interactions between proteins are denoted by teeth.
Potential interactions are modeled between a single roX transcript (black line)
and proteins reported to have RNA-binding activity. Protein/protein and
protein/RNA interactions are reported by Akhtar et al. (2000); Buscaino et al.
(2003); Copps et al. (1998); Li et al. (2005); Morales et al. (2004); Scott et al.
(2000).
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as elimination of either of these proteins prevents all chromatin binding by
remaining complex members (Lyman et al., 1997). In contrast, simultaneous
elimination of both roX RNAs shifts the MSL proteins from the X chromosome to
ectopic autosomal sites and results in reduced X-linked gene expression (Deng
and Meller, 2006; Deng et al., 2005; Meller and Rattner, 2002). Recognition of
the X chromosome is thus a property of the intact MSL complex, and is not
attributable solely to a single participating molecule.

Proteins associated with the MSL complex modify chromatin
Increased expression of the male X chromosome is believed to result from
changes in chromatin architecture induced by MSL complex. One member of the
MSL complex, MOF, is an acetyltransferase specific for lysine 16 of histone H4
(Akhtar and Becker, 2000; Hilfiker et al., 1997; Smith et al., 2000). This
modification is generally associated with active chromatin, and is highly enriched
on the male X chromosome of flies (Turner et al., 1992). Acetylation of H4K16 by
MOF increases transcription in vitro and in vivo (Akhtar and Becker, 2000).
Effector proteins that mediate transcriptional change bind to some modified
histones, but none specific for H4K16ac has been found. A study demonstrated
that acetylation of H4K16 inhibits the formation of highly compact chromatin by
disrupting charge-based internucleosomal interactions (Shogren-Knaak et al.,
2006). This structural effect partially decondenses chromatin, thereby increasing
the accessibility of the DNA template. In humans, H4K16ac is found ubiquitously
on all chromosomes except for the inactive X chromosome (Jeppesen and
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Turner, 1993). In flies, H4K16ac is found at the promoter region on both X-linked
and autosomal genes in both sexes, but only in males displays a bimodal
distribution to promoters and the 3’ ends of X-linked genes (Gelbart et al., 2009;
Kind et al., 2008). These findings suggest that H4K16ac has a general role in
Drosophila gene expression. However, the role of MOF, and even whether MOF
is responsible for 5’ H4K16ac, remains controversial (Gelbart et al., 2009; Kind et
al., 2008). On the male X chromosome, H4K16ac colocalizes with the MSL
complex in the body of actively transcribed genes (Bone et al., 1994; Gelbart et
al., 2009; Smith et al., 2001; Turner et al., 1992). However, the distribution of
H4K16ac is much broader than MSL complex (Gelbart et al., 2009). It is
supposed that broad H4K16ac distribution is due to transient association of the
MSL complex, or chromosome looping that allows the complex to modify distant
histones.
A second modification linked to increased expression, phosphorylation of
H3 on serine 10 (H3S10p), is also enriched on the male X chromosome (Jin et al.,
1999; Mahadevan et al., 2004). H3S10p, produced by the aurora kinase, is
abundant on mitotic chromosomes (Adams et al., 2001; Giet and Glover, 2001).
In interphase cells, H3S10p is directed by the JIL-1 kinase (Wang et al., 2001).
Proper dosage compensation of the X-linked white gene requires JIL-1 function
(Lerach et al., 2005). In addition to compensation of the male X chromosome,
JIL-1 has a general role in maintenance of chromatin structure and limits the
spread of heterochromatin into euchromatic regions (Zhang et al., 2006).
Accordingly, JIL-1 is an essential gene required in both sexes (Wang et al., 2001).
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The male X chromosome is therefore marked with at least two histone
modifications that are associated with elevated transcription. Recently MSL2 was
illustrated as an E3 ubiquitin ligase for histone H2B (Wu et al., 2011). This
ubiquitylation then crosstalks with histone H3 K4 and K79 methylation. It is likely
that the primary function of the MSL complex is to direct and control these
modifications.

The MSL complex increases transcription by a general method
X chromosome compensation affects hundreds of genes with different
expression levels and profiles. It must therefore be superimposed on genes with
distinct regulatory strategies. Interestingly, chromatin immuno and affinity
precipitation of DNA bound by the MSL complex detects modest levels of these
proteins in promoter regions, but higher levels within the body of most actively
transcribed X-linked genes in males, with a bias towards 3’ ends (Alekseyenko et
al., 2006; Gilfillan et al., 2006; Legube et al., 2006). H4K16ac has also been
found to be high in the body of X-linked genes in males (Gelbart et al., 2009;
Kind et al., 2008; Smith et al., 2001). The reduced compaction of chromatin
enriched with H4K16ac may increase the speed or processivity of RNA
polymerase within the body of genes. Enhanced expression is thus likely to result
from facilitation of transcriptional elongation, rather than increased initiation
(Henikoff and Meneely, 1993). This hypothesis is verified by a recent genomewide gene run-on study from isolated nuclei to examine the effect of the MSL
complex on RNA Polymerase II (Larschan et al., 2011). However, the possibility
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that modifications at the 3’ end of transcription units enhances reinitiation by
recycled RNA polymerase has not been eliminated (Dieci and Sentenac, 2003).
A second theory for how the MSL complex enhances expression stems
from a study of proteins copurifying with tagged MOF and MSL3 (Mendjan et al.,
2006). This study found no classical transcriptional factors but identified exosome
components, interband binding proteins and nuclear pore components in
association with MSL proteins. Knock down of the nuclear pore proteins Mtor and
Nup153 disrupted the location of MSL proteins and compensation of some Xlinked genes, suggesting that interaction with the nuclear pore is important for
localization of the MSL complex (Mendjan et al., 2006). An association with the
nuclear pore might facilitate transcriptional elongation by affecting RNA
processing and transportation. Alternatively, the nuclear pore might establish a
transcriptionally active compartment, or a region of facilitated chromatin
remodeling within the nucleus (Casolari et al., 2005; Feuerbach et al., 2002).
Tethering transcription units to nuclear pores facilitates expression in yeast,
supporting the involvement of this structure in activation (Cabal et al., 2006;
Taddei et al., 2006). Recruitment of silenced genes into a repressive nuclear
compartment has been proposed as the mechanism of X-chromosome
inactivation in mammals. The inactive X chromosome (Xi) occupies a region
adjacent to the nucleolus during replication (Zhang et al., 2007). This may ensure
epigenetic maintenance of the silent state through replication. X-linked gene
inactivation is accompanied by movement of individual genes from the outer
fringe of the domain occupied by the Xi to a more interior position from which
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RNA polymerase is excluded (Chaumeil et al., 2006). Thus X inactivation and its
perpetuation may rely on recruitment of genes and the X chromosome into
specific

nuclear

compartments.

Recent

studies

suggest

that

dosage

compensation in flies may involve repositioning of genes in a transcriptionally
active domain (Grimaud and Becker, 2009). Dosage compensated genes on the
X chromosome were closer together in interphase nuclei from males than in
those from females. This was dependent on MSL proteins, indicating that these
proteins promote a male-specific conformation of the X chromosome. The idea of
a dosage compensated nuclear compartment is appealing as it provides a
mechanism through which compensation can be superimposed on genes with
different regulatory strategies on one chromosome.

Large RNAs that control X chromosomes: powerful but mysterious
molecules
Regulatory RNAs that coat the X chromosome play a key role in dosage
compensation in mammals and Drosophila. In spite of the central role of roX
transcripts in fly dosage compensation, how they interact with the MSL proteins,
and how this changes the properties of the MSL complex, remains speculative. A
comparison with Xist may prove valuable. Xist is well studied and shares unusual
properties with the roX RNAs. Both RNAs coat dosage-compensated X
chromosomes, direct protein complexes to chromatin, and are able to recruit
chromatin-modifying activities in cis to the site of RNA synthesis.
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Xist is transcribed from the Xic (X inactivation center) and is essential for
initiation and propagation of X-chromosome inactivation in mammals (reviewed
by (Plath et al., 2002). Xist is selectively expressed from one X chromosome and
spreads in cis from the site of synthesis to coat most of the inactive X
chromosome (Xi). Xist recruits Polycomb proteins that introduce repressive
histone modifications (Plath et al., 2004; Silva et al., 2003). Several days after
the initiation of X inactivation, the inactivation becomes largely independent of
Xist. Additional changes in chromatin, such as enrichment for variant histones
and methylation of CpG islands, characterize the differentiated Xi (reviewed by
(Lucchesi et al., 2005). Distinct sequences within Xist are responsible for
localization to the X chromosome and for silencing (Figure 1-3 A, (Wutz et al.,
2002)). Several widely separated Xist sequences act cooperatively to direct X
localization, and a repeated element that folds into short stem loops mediates
silencing as well as localization (Wutz et al., 2002). This repeat is also necessary
for relocalization of silenced genes inside the domain occupied by the Xi
(Chaumeil et al., 2006).
roX1 also has multiple regions necessary for function (Figure 1-3 B). In
spite of their redundancy, roX1 and roX2 share little sequence similarity that can
be used to identify potentially important sequences (Amrein and Axel, 1997; Park
et al., 2003). Several highly conserved “roX boxes” (short GUUNUACG
sequences) are present at the 3’ end of both roX RNAs (Franke and Baker, 1999;
Park et al., 2008). A stem loop at the 3’ end of roX1 is formed in part by roX box
sequences. These conserved 3’ “roX boxes” are able to form alternative stem
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Figure 1-3. roX1 and Xist have distinct regions necessary for gene function.
(A) The Xist transcript has a series of 15 short stem loops near the 5’ end that
are necessary for silencing. Distributed elements that contribute to X localization
are shown as gray and white boxes. The strongest of these are darkest. Figure is
based on (Wutz, 2003; Wutz et al., 2002). (B) Functional and conserved regions
of roX1 RNA (top) and DNA (bottom) are represented. One kb at the 5’ end of
roX1 (open box on left) is necessary for wild-type localization of the MSL
complex. Between this and the 3’ stem loop (right) there is no identified element
necessary for RNA function. The 200 bp roX1 DNase hypersensitive site (DHS)
is shown as a gray box on the roX1 DNA. This sequence attracts the MSL
complex. The “roX boxes” (black) are at the right. This is based on (Kageyama et
al., 2001; Park et al., 2003; Stuckenholz et al., 2003; Park et al., 2008).
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loops (Kelley et al., 2008; Park et al., 2008). Transgenes deleted for the stem
loop or with disrupted pairing of the stem have low rescue of roX1 roX2 males in
spite of substantial recruitment of MSL proteins to the X chromosome
(Stuckenholz et al., 2003). The stem loop is therefore expected to influence
chromatin modification or gene activation by the MSL complex, rather than X
chromosome targeting. This is supported by studies revealing that the histone
acetyltransferase activity of the MSL complex requires elements in the 3' end of
roX1 (Kelley et al., 2008; Park et al., 2008; Stuckenholz et al., 2003). A weakly
conserved 200 bp sequence within each roX gene strongly attracts the MSL
proteins and forms a male-specific DNaseI hypersensitive site (Kageyama et al.,
2001; Park et al., 2003). The roX1 DNaseI hypersensitive site (DHS) acts as an
enhancer of roX1 transcription in males and a repressor in females (Bai et al.,
2004). However, internal deletions of roX1 lacking the DHS are still regulated in a
sex-specific manner, and roX1 alleles and transgenes lacking this sequence
retain full activity (Deng et al., 2005; Rattner and Meller, 2004; Stuckenholz et al.,
2003). Although the role of the DHS remains speculative, all evidence points to
its function as DNA, rather than RNA.
Deletion of 1 kb at the 5’ end of roX1 also destroys activity. When large
portions of this region are removed by internal deletion, roX1 activity is reduced
commensurate with the amount deleted (Deng et al., 2005). Small (<300 bp)
deletions scanning the 5’ end have failed to identify discrete elements,
suggesting redundancy (Stuckenholz et al., 2003). Males that carry a roX1 allele
with a large part of the 5’ end missing display ectopic MSL binding and reduced
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coverage of the X chromosome, suggesting that this region is necessary for
recognition of the X chromosome (Deng et al., 2005). An internal deletion of 2.4
kb that retains 0.8 kb of 5’ end and 0.6 kb of the 3’ end, including the stem loop,
supports full male survival (Deng et al., 2005). However, simultaneous
expression of separate 3’ and 5’ fragments of roX1 does not rescue either MSL
localization or male survival (Meller and Rattner, 2002; Stuckenholz et al., 2003).
Taken together, these observations suggest that roX activity requires
simultaneous interaction with different molecules. An attractive model is that roX1,
like Xist, has distinct domains necessary for X chromosome localization and
gene activation.
The major roX2 splice form is 600 bp, but a multitude of alternative roX2
splice forms with decreased activity has been found (Park et al., 2005). roX2
molecules with different levels of activity may modulate the activity of the MSL
complex, thus fine-tuning the level of X chromosome activation.

MSL proteins have RNA-binding activity
MLE is an ATP-dependent RNA/DNA helicase with higher activity on RNA
substrates (Lee et al., 1997). The ATPase activity is necessary for transcriptional
enhancement by the MSL complex (Morra et al., 2008). The helicase activity of
MLE is essential for normal localization of the MSL complex on the X
chromosome, and for movement of the roX RNAs from their sites of synthesis,
suggesting that MLE may integrate roX into the mature MSL complex (Gu et al.,
2000; Meller et al., 2000; Morra et al., 2008). MLE itself does not interact with
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other MSL proteins and can only be coimmunoprecipitated under nonstringent
conditions using antibodies that pull down other MSL proteins (Smith et al., 2000).
MLE can be released from polytene chromosomes by RNase A digestion,
suggesting that it associates with the MSL complex through an RNA (Figure 2B;
(Richter et al., 1996)). The stability of roX1 is particularly dependent on MLE,
supporting the idea of a direct interaction between these molecules (Meller,
2003).
Both MSL3 and MOF have RNA-binding activity in vitro and their
localization on the X chromosome is destabilized by RNase digestion (Akhtar et
al., 2000; Buscaino et al., 2003). Both proteins have variant chromo domains that
have been implicated in RNA binding. Whereas the canonical chromo domains of
Heterochromatin protein 1 (HP1) and Polycomb (Pc) contain aromatic residues in
a recognition site that binds methylated histones, the variant structures found in
MOF and MSL3, named chromo barrel domains, may have different functions
(Bannister et al., 2001; Lachner et al., 2001). The MOF chromo barrel domain
lacks particular residues that recognize methylated peptides (Nielsen et al.,
2005). This region contributes to MOF’s ability to bind RNA in vitro (Akhtar et al.,
2000). The chromo barrel domain of MSL3 has also been implicated in RNA
binding, but retains the aromatic residues necessary for methyl group binding
(Nielsen et al., 2005). A previous study showed that mutation of the MSL3
chromo barrel domain prevents increased transcription of X-linked genes, but
does not affect localization of the complex to the X chromosome (Buscaino et al.,
2006). However, a later study showed that the MSL3 chromo barrel domain binds
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histone H3 Lysine 36 trimethylation (H3K36me3), and this is essential for MSL
spreading into transcribed regions of the X chromosome (Sural et al., 2008). The
failure of Buscaino et al. to see any effect of mutation of the MSL3 chromo barrel
domain on binding of the complex to the X chromosome may due to the low
resolution of polytene chromosome immunostaining. The decreased expression
of X-linked genes in the MSL3 chromo barrel domain mutant is likely the result of
failure of the MSL complex to spread onto active genes.
The H4 acetyltransferase activity of MOF is greatly increased by
association with MSL1 and MSL3, suggesting a mechanism for limiting MOF
activity until it assembles with a regulatory complex (Morales et al., 2004). MSL1,
2, 3, and MOF continue to associate in the absence of roX, but only low levels of
H4K16ac are detected at sites bound by these proteins (Deng and Meller, 2006).
This may reflect a reduced MOF activity in the absence of roX RNA. Taken
together, these studies suggest that multiple RNA/protein and protein/protein
contacts within the MSL complex are necessary for precise regulation of the
activity of the MSL complex.

Do roX and MLE recruit a preexisting chromatin-binding complex?
The discovery that the yeast NuA4 transcriptional regulator contains
subunits similar to MSL3 and MOF, and characterization of a mammalian
complex containing MSL homologs suggests that the association of these
proteins is ancient (Eisen et al., 2001; Marin and Baker, 2000; Smith et al., 2005;
Taipale et al., 2005). Human MOF (hMOF) participates in multiple protein
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assemblies and is required for normal function of human ATM (ataxiatelangiectasia-mutated) protein in DNA repair (Gupta et al., 2005; Taipale et al.,
2005).
roX RNAs have only been identified in closely related Drosophilids, but
helicases with similarity to MLE have been identified from yeast to mammals
(Park et al., 2003; Sanjuan and Marin, 2001). MLE homologs have not yet been
isolated in complexes of MSL-like proteins outside of flies. MLE has a peripheral
association with the fly MSL complex, and is presumably tethered by RNA. It thus
seems plausible that the addition of MLE to the MSL complex depends on the
presence of roX. The importance of roX in correct targeting of the MSL complex
suggests that the addition of noncoding RNA was a major step in recruitment for
the purpose of X chromosome compensation.

Recognition of X chromosomes
A mechanism that targets changes in expression to a single chromosome
is a fundamental requirement of dosage compensation. Two distinct strategies
for accomplishing this have been described. The chromosome may be controlled
by a cis-acting element. The Xic is a strong cis-acting element capable of
directing silencing to the entire X chromosome (Figure 1-4 A). The Xic can also
silence autosomal chromatin if inserted on an autosome (Lee and Jaenisch, 1997;
Lee et al., 1996; Wutz and Jaenisch, 2000). Xist RNA produced from the Xic
does not work in trans, thus protecting one X chromosome from inactivation. An
alternative mechanism for distinguishing a chromosome is finely dispersed
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Figure 1-4. Strategies for X chromosome recognition in mammals, flies and
worms. (A) One of two X inactivation centers present in females produces Xist
RNA (top left). The chromosome carrying this allele becomes the inactive X
(shaded). A transgene carrying Xist can silence autosomal chromatin in cis
(shaded, right). (B) The C. elegans X chromosome is distinguished by sequence
elements (gray shading). The distribution of these elements is uneven, leaving
large gaps (white). The repressive DCC spreads into these gaps from flanking
regions. Segments separated from the rest of the X chromosome attract the DCC
if they have X-recognition sequences (autosomal insertion, top) but remain
uncompensated if they lack these elements (autosomal insertion, bottom). (C)
The Drosophila X chromosome is finely marked by sequences that attract the
MSL complex (gray). Translocated X chromosome fragments are recognized
accurately (autosomal insertion, bottom). Weak and scattered MSL-binding sites
on the autosomes do not attract the MSL complex in normal males (gray lines,
right). roX1 and roX2 (vertical black lines) produce roX RNA and are cis-acting
elements that enhance recognition of the X chromosome. A roX transgene (top
right) enables MSL binding to closely linked autosomal sites. The roX transgene
also produces transcript that acts in trans to compensate an X chromosome.
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sequence elements. Two short sequences that participate in recognition of the C.
elegans X chromosome have been identified (McDonel et al., 2006). Interestingly,
these are not exclusive to the X but are found near one another on the X
chromosome. This suggests that cooperativity between multiple DNA-binding
molecules underlies recognition X chromatin in worms. However, large regions of
the C. elegans X chromosome fail to bind the repressive dosage compensation
complex (DCC) when separated from the X chromosome, but are coated by it
when on the X chromosome (Figure 1-4 B) (Csankovszki et al., 2004). This
indicates that the ability of the DCC to spread in cis is necessary for a complete
coverage of the C. elegans X chromosome.
Translocated segments of the Drosophila X chromosome are faithfully
recognized by the MSL complex, indicating the presence of finely distributed
sequences marking this chromosome (Figure 1-4 C, (Fagegaltier and Baker,
2004; Oh et al., 2004)). In addition, autosomal roX transgenes can fully rescue
male viability, indicating that roX RNA can act in trans to its site of synthesis. But
under some conditions, autosomal roX insertions also direct MSL binding to
chromatin flanking the insertion site (Kelley et al., 1999; Park et al., 2002).
Regional spreading of chromatin modification from the roX genes can also be
observed on the X chromosome (Bai et al., 2007; Oh et al., 2003). It therefore
appears that recognition of the Drosophila X chromosome involves strong, cisacting elements as well as sequences identifying the X chromosome.
Subdivision of DNA clones that recruit the MSL complex and a functional
assay for MSL recruitment have identified short sequences that contribute to
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MSL binding (Dahlsveen et al., 2006; Gilfillan et al., 2007; Oh et al., 2004). These
sequences are divergent and display a wide range in affinity for the MSL proteins.
More recently, ChIP-chip and ChIP-seq studies identified over one hundred MSL
High Affinity Sites (HAS), also called Chromatin Entry Sites (CES) on the X
chromosome (Alekseyenko et al., 2008; Straub et al., 2008). These are regions
that retain residual MSL binding in an msl3 mutant background. A GA-rich MSL
recognition element (MRE) has been identified within the CES (Alekseyenko et
al., 2008). However, the MRE consensus is only two-fold enriched on the X
chromosome, compared to the autosomes (Alekseyenko et al., 2008; Straub et
al., 2008). Many MREs on the X chromosome do not reside within a CES.
Therefore, the MRE is not the only feature that forms a CES or distinguishes X
and autosomal chromatin. An attractive hypothesis is that a dense distribution of
MREs and weak recruitment sites act cooperatively to mark the X chromosome
(Dahlsveen et al., 2006; Demakova et al., 2003; Fagegaltier and Baker, 2004).
Local elevation of the MSL complex by strong sites will enable weaker ones to be
bound. The DHS within the roX1 and roX2 genes are extraordinarily strong MSL
recruitment sites (Kageyama et al., 2001). Both roX genes can induce binding of
the MSL complex in autosomal chromatin flanking transgene insertions, likely
due to enhancement of weak autosomal binding sites (Dahlsveen et al., 2006;
Kelley et al., 1999). Although not absolutely essential for compensation, the
situation of the roX DHS on the X chromosome will enhance recognition of the X.
Additional features, such as features linked to actively expressed genes might be
also important to distinguish functional MREs on X chromosome.
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X chromosome binding of the MSL proteins is disrupted in roX1 roX2
males, but these proteins continue to colocalize at ectopic autosomal sites. The
roX transcripts are therefore not essential for chromatin binding, but ensure high
selectivity of the intact MSL complex for the X chromosome. Assembly with roX
might enhance the ability of the MSL complex to recognize sequence elements
on the X chromosome. Alternatively, a change in the complex following roX
incorporation could promote cooperative binding at closely situated sites. This
would favor the X chromosome, proposed to have dense mix of strong and weak
sites, over the autosomes, which have more scattered sites capable of recruiting
MSL proteins (Demakova et al., 2003).
The distribution of the MSL complex in the body of active genes suggests
that localization is largely established by transcriptional activity (Alekseyenko et
al., 2006; Gilfillan et al., 2006; Legube et al., 2006). This could occur by
association with the transcription machinery or interaction with nascent
transcripts. Alternatively, the MSL complex could be targeted to modified
histones in the wake of a transcribing polymerase. The MSL3 chromodomain
binds histone H3 Lysine 36 trimethylation (H3K36me3), which marks active
genes, supporting this mechanism (Sural et al., 2008). These methods would
identify transcribed regions, but are unable to distinguish between X-linked and
autosomal genes. The current model for establish MSL binding is a two step
model: first, sequence-dependent MSL recognition of speciﬁc chromatin entry
sites on the X chromosome occurs, followed by sequence-independent
spreading to active genes. Closely linked genes will be transcribed in proximity to
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one another, and thus may be influenced by their neighbors. Linked mammalian
genes often associate at “transcription factories” (Osborne et al., 2004). Although
there is no evidence for analogous transcription factories in Drosophila,
identification of nuclear pore proteins in association with the MSL complex
suggests recruitment to a particular region of the nucleus. It is possible that some
elements marking the X chromosome direct transcribed genes to regions where
MSL loading can occur, rather than interacting directly with the MSL complex
itself. For example, a male-specific conformation of the X chromosome that
clusters the CES may facilitate distribution of the MSL complex along the X
chromosome (Grimaud and Becker, 2009).

Concluding remarks
Dosage compensation in Drosophila is a remarkable model for the study
of epigenetic regulation. It is also rich in common principles of chromatin-based
transcription control. Regulation of the male X chromosome involves histone
modifications that are proposed to act by increasing the speed, processivity, or
reinitiation rate of RNA polymerase. Similar mechanisms will be relevant for the
regulation of all eukaryotic genes. Modification of the Drosophila X chromosome
is directed by cues including cis-acting DNA elements, transcriptional activity and
possibly recruitment to regions where MSL loading is promoted or transcription is
facilitated. Together these produce highly selective recognition and modulation of
a single chromosome. Understanding how noncoding RNAs such as roX
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coordinate this process will enhance our understanding of epigenetic processes
in all eukaryotes.

Project outline
Non-coding RNAs are postulated to be involved in gene regulation in
many different ways. One of the important ways is the involvement of roX RNA in
the chromosome-wide gene regulation that occurs during dosage compensation
in Drosophila. In this dissertation, I present my work on the structural and
functional analysis of roX1 RNA. In Chapter 1, I introduce background
information about dosage compensation, the MSL complex, recognition of X
chromosome and how the MSL binding pattern is established.
In Chapter 2, I examine whether roX RNA contributes to the expression of
autosomal genes in Drosophila females. I show that roX1 has no detectable
affect on gene expression in females, although present in female embryos. I also
analyze candidate regions suspected of involvement in regulating autosomal
genes.
In Chapter 3, I dissect the function of the 5' end of roX1, a region critical
for localization of the MSL complex. I describe the generation and analysis of
roX1 transgenes containing different sections of the 5’ end. I show that multiple
redundant elements contributing to X chromosome targeting are present
throughout the 5’ end of roX1. I also show that the extreme 5’ roX1 region has a
unique function that promotes MSL complex spreading from sites of roX1
transcription. Paradoxically, a transgene containing this region is unable to recruit
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MLE to the X chromosome. I then show that all of the 5’ roX1 transgenes display
different stability, but all can partially restore X-linked gene expression in roX
mutant. roX1 has multiple transcription start sites that produce several isoforms.
My work suggests that the choice of transcription start site will have a striking
effect on roX1 function.
Data from these studies provide initial insight into the mechanism of a
chromosome-wide regulation by a large non-coding RNA. Our results generate
some interesting questions. Chapter 4 is a summary of my study and
perspectives for future study that are based on my findings.
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CHAPTER 2

FUNCTION OF roX RNAS IN REGULATION OF AUTOSOMAL GENES IN
DROSOPHILA

Part of the work described in this chapter has been published in ‘Deng X.,
Koya S.K., Kong Y., and Meller V.H. (2009) Coordinated regulation of
heterochromatic genes in Drosophila melanogaster males. Genetics. 182(2):
481-491.’

INTRODUCTION

Many organisms have two X chromosomes in females but only one X
chromosome and a Y chromosome in males. The X chromosome is gene-rich
and majorly euchromatic. By contrast, the Y chromosome is often gene-poor, and
largely

heterochromatic

(Charlesworth,

1991).

Highly

differentiated

sex

chromosomes result in imbalance of the dosage of X-linked genes that is fatal if
not addressed early in life. Dosage compensation is the process which equalizes
expression of X-linked genes between males and females. Although strategies
for equalizing expression differ between species, there is a unifying theme which
involves a coordinated regulation of the whole X chromosome through
modulation of chromatin architecture. This is mediated by selective recruitment of
chromatin modifying proteins (Lucchesi et al., 2005). In Drosophila, the male
speciﬁc lethal (MSL) complex is the chromatin modifying complex which
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selectively binds the male X chromosome and increases expression from the
male X chromosome about two fold to achieve the dosage compensation.
The MSL complex is composed of both proteins and noncoding RNAs.
Two noncoding RNAs, roX1 and roX2 (RNA on the X 1 and -2), are essential
components of MSL complex (Meller and Rattner, 2002). roX RNAs assemble
with five MSL proteins, the Male Speciﬁc Lethals 1, -2, and -3 (MSL1, MSL2, and
MSL3), Maleless (MLE) and Males Absent On First (MOF), to form the complex.
The MSL complex binds numerous sites on the X chromosome and acetylates
histone H4 on lysine 16 (H4K16ac), which ultimately increases expression of the
whole X chromosome (Akhtar and Becker, 2000). roX1 and roX2 RNAs are
functionally redundant. Deletion of a single roX gene shows no phenotype, but
simultaneous mutation of both roX genes is lethal in males (Meller and Rattner,
2002). A microarray study of roX1 roX2 male larvae revealed a global decrease
of X-linked gene expression, which conﬁrmed that roX RNAs are necessary for
full expression of dosage compensated genes in males (Deng and Meller, 2006).
The highly specific binding of the MSL complex to the X chromosome
suggested the idea that the MSL components contribute solely to X-linked gene
expression. However, expression of virtually all genes on the small fourth
chromosome also decreased in the absence of both roX transcripts (Figure 2-2A,
B, (Deng et al., 2009)). This finding suggested that there are other functions of
MSL components beyond dosage compensation. In agreement with this, some of
the MSL proteins act as general transcriptional regulators outside of the complex.
Both MLE and MOF are found at autosomal sites of active transcription in males
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and females (Kind et al., 2008; Kotlikova et al., 2006). But their role as general
transcriptional regulators is not essential, as mutations in mle and mof are not
lethal in females.
The fourth chromosome of Drosophila is a tiny chromosome, containing
only around 100 genes. It is enriched for heterochromatin, consisting of
interspersed heterochromatic and euchromatic regions (Locke et al., 1999;
Riddle and Elgin, 2006). Many fourth-linked genes contain these heterochromatic
regions. Genes within or near heterochromatin have specialized regulatory
features that enable their expression in this repressive environment (Yasuhara
and Wakimoto, 2006). It is possible that the heterochromatic feature of the fourth
chromosome contributes to its regulation by roX RNAs. Studies in our lab
confirmed that roX RNAs are required for full expression of heterochromatic
genes in male larvae, including those on the fourth chromosome and in
heterochromatic regions of the second and third chromosomes (Figure 2-3A,
(Deng et al., 2009)).
Investigation of the genetic basis of heterochromatic regulation revealed
that MSL1, MSL3 and MLE, but not MSL2, are also necessary for normal
expression of heterochromatic genes in males (Deng et al., 2009). MSL2 is the
only member of the MSL complex that is only expressed in males, thus limiting
MSL complex assembly to males (Rastelli et al., 1995). Regulation of
heterochromatic genes is therefore not mediated by the intact MSL complex. All
of the MSL proteins necessary for regulation of heterochromatic genes are
present in females (Rastelli et al., 1995). roX1 is also present in female embryos
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(Meller, 2003). Since females have roX1, and the MSL proteins necessary for
regulation of heterochromatic genes, I asked if roX RNA also regulates
heterochromatic gene expression in females. To do this, I compared genomewide expression in roX1 roX2 females with that of control females. I discovered
that roX RNAs do not affect expression of the female fourth chromosome and
heterochromatic genes, revealing that regulation of these genes by roX RNAs is
male-limited.
What limits roX-dependent regulation of heterochromatic genes to males
is still mysterious. Our preliminary data suggested a candidate roX1 region that
might contribute to regulation of heterochromatic genes. I tested this by
comparing gene expression in roX1 roX2 males carrying transgenes with and
without this region. I found that this region has no influence on the expression of
heterochromatic genes. Sexlethal (SXL) is a multifunctional RNA-binding protein
that controls sexual differentiation in flies. The SXL protein is only expressed in
females and determines the sexual development by modulating the expression of
a set of downstream genes (reviewed in (Salz and Erickson, 2010)). It is
expected that all sex-limited processes will be directly or indirectly regulated by
SXL. SXL inhibits expression of MSL2 in females (Bashaw and Baker, 1997;
Kelley et al., 1997; Penalva and Sanchez, 2003). MSL2 is, in turn, essential for
roX expression and stability in older animals, but not in embryos (Rattner and
Meller, 2004). roX1 has two potential SXL binding sites in a small intron (Figure
2-5A, (Meller et al., 1997)). The function, if any, of these sites is unknown, but it is
possible that they bind SXL in females, limiting the ability of roX1 to regulate
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heterochromatin. I examined the possibility that SXL binding to roX1 inhibits its
function in female heterchromatin by comparing gene expression in females
carrying transgenes lacking the SXL binding site to wild type females. I
demonstrated that deletion of the SXL binding site did not enable roX1 to
regulate heterochromatic genes in females.
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MATERIALS AND METHODS

Drosophila strains
Flies were maintained in vials containing standard cornmeal agar media at
25°C. The roX1SMC17A and roX1ex33A mutations have been previously described
(Deng et al., 2005). Df(1)52 is a lethal deletion of roX2 and essential ﬂanking
genes. Elimination of roX2 is accomplished by complementing Df(1)52 with
[w+4∆4.3], a cosmid insertion carrying essential deleted genes but lacking roX2
(Meller and Rattner, 2002). For convenience this combination is referred to as
roX2.

Generation of a full length roX1 expression construct
To create a full length roX1 transgene, the 5’ end of a slightly truncated 4.1
kb roX1 genomic fragment (roX1 bp 42-4165, numbering from (Amrein and Axel,
1997) is used throughout) was replaced by a fragment containing the entire 5’
end of roX1 (starting from roX1 bp -78). The missing 5’ fragment was generated
by PCR amplification of genomic DNA from wild type flies using oligonucleotides
roX1 F-78 and roX1 R1262 (Table 2-1), and subcloned into pCR4-TOPO
(Invitrogen). A BamHI site is present in roX1 F-78 and a MluI site is present in
roX1 R1262. A 1.3 kb roX1 BamHI-MluI fragment from the pCRT-TOPO clone
was used to replace a 1.2 kb BamHI-MluI fragment from the existing roX1 clone.
The full length roX1 was released by EcoRI and ligated into a modified pUASTB.
pUASTB is a transformation vector carrying an attB site and a mini-white gene
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(Groth et al., 2004). pUASTB was modified by introducing the strong and
constitutive hsp83 promoter. The hsp83 promoter was amplified from the
pCasper HS83T3 vector (Meller et al., 2000) by PCR (primers in Table 2-1). A
KpnI site was introduced at the 5’ end and BamHI, EcoRI and SacII sites were
introduced at the 3’ end. A KpnI-SacII fragment containing the hsp83 promoter
was subcloned in the pUASTB vector. The unique BamHI and EcoRI sites were
used to clone roX1 adjacent to the promoter.

Generation of transgenic flies
The full length roX1 transgene was integrated at 16C1 on the X
chromosome and at 68A4 on the third chromosome using the site-specific C31
integrase system (Groth et al., 2004). Stocks with an insertion of an attP landing
site P[y+CaryattP] at 68A4 were obtained from the Bloomington Drosophila stock
center. Mobilization of this P element was accomplished by introducing a
transposase source (TMS, Sb P[ry+t7.2∆2-3]99B) and selecting for insertions on
the X chromosome (P. Frolov, unpublished). The exact location of the 16C1 Xlinked insertion was determined by inverse PCR and sequencing (Inverse PCR
Protocol available from Berkeley Drosophila Genome Project; http://www.fruitfly.
org/about/methods/inverse.pcr.html). My construct was injected into Drosophila
embryos derived from mating female virgins carrying P[y+CaryattP] with males
having a C31 integrase transgene on the third chromosome. Adult flies derived
from injected embryos were mated to yw, and transgenics expressing the miniwhite marker identified in their offspring. Transgenics were made homozygous,
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Table 2-1. Primers used for creation and confirmation of roX1 transgenes,
and for confirmation of integration.
Primers

Sequences (5’ – 3’)

roX1 F-78

AGGATCCGAATTCGCGGCGTTACCGGCTCG

roX1 R1262

GTACGCGTCTTCTCGAAACGCAAGTGGCGA

hsp83 Link F

ATGGTACCGATGATCCTTAACGGGGAACTTG

hsp83 Link R

AGCCGCGGGAATTCGGATCCTCGACGGTATCGATAAGCTAG

hsp83 662F

TTCGGACCACTTAGACGAATTT

roX1 F8

TCAGTGTTCAGCACCTCGTC

roX1 R8

TTTTGGGCACTTGGTGAAG

y1456F

GGTCCACCGTTATATACGAAACA

BPR08wh

TAGCTCCTGATCCTCTTG

attB_210R

TGACCGTCGAGAACCCGCTGACG
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and integration of the transgenes was verified by single fly PCR using primers in
the P[y+CaryattP] target site (y1456F) and pUASTB transgene (BPR08wh) (Table
2-1).

Generation of roX1 roX2 and control females with identical genetic
background
The genotype of mutant females used for the Microarray gene expression
study is roX1SMC17A roX2. roX1SMC17A is a severe roX1 allele that has a complex
rearrangement with bp 204–2362 replaced by a LacZ gene, the SV40 poly
adenylation signal and 3’ P-element end (Deng et al., 2005). All subsequent
studies in this chapter use this allele. A previous study to compare gene
expression in roX1 roX2, roX1+ roX2 and roX1 roX2+ females produced
ambiguous results, probably because of differences in genetic background
between strains. To eliminate this effect, roX1SMC17A roX2 mutant and control
females that have identical genetic background were generated. Control females
contain the same roX1SMC17A roX2 X chromosome, but carry a [w+Hsp83-roX1+]
transgene. The [w+Hsp83-roX1+] transgene is a 4.1 kb roX1 genomic fragment
(roX1 bp 42-4165) driven by the hsp83 promoter. It rescues both male survival
and X localization of the MSL proteins (V. Meller, data unpublished). The genetic
crossing scheme to generate control females is shown in Figure 2-1.

Total RNA isolation
Total RNA was extracted from three groups of fifty third instar larvae of
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Figure 2-1. The crossing scheme for generating mutant and control females
with identical genetic background for microarray study. “+” represents a wild
type chromosome, X means cross.
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each genotype using TRIzol (Invitrogen). Briefly, fifty third instar larvae were
homogenized in 1ml of TRIzol by Tissue Tearor (Model 985-370, Biospec
Products, Inc.). After centrifugation at 12000 rpm for 12 minutes, the supernatant
was transferred into a new tube, mixed with 0.2ml chloroform and centrifuged
again at 12000 rpm for 15 minutes. The aqueous phase was transferred into a
new tube. Total RNA was precipitated by adding 0.5ml of isopropanol to the
aqueous phase. The RNA pellet was washed with 75% ethanol, air dried, and
dissolved in 50µl RNase-free water. Total RNA was then purified using the
RNeasy Mini Kit following instructions (Qiagen).

Quantitative RT–PCR
1µg of total RNA was reverse transcribed at 42 °C for 1 hour using random
hexamers and ImProm-II reverse transcriptase (Promega). The reverse
transcription reaction consisted of 1 µg RNA template, 0.5 µg random hexamers
(primers), 3 mM MgCl2, 0.5 mM dNTP mix, 0.5 µl Recombinant RNasin (RNase
inhibitor), 1 µl ImProm-II reverse transcriptase (Promega) and 4 µl 5XImProm-II
reaction buffer in a total volume of 20 µl. Quantitative PCR was performed as
previously described (Deng et al., 2005) using an Mx3000P Realtime PCR
system (Stratagene). Briefly, two PCR reactions for each template were
performed in parallel. Each PCR reaction consisted of 5 µl cDNA template (1:20
dilution), 0.3 µM of each primer, and 12.5 µl 2XSYBR Green PCR Master Mix
(Applied Biosystem) in a total volume of 25 µl. Q-RT–PCR data were analyzed
by the efﬁciency corrected comparative quantiﬁcation method (Pfaffl, 2001). Ct
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Table 2-2. Primers used for Q-RT-PCR analysis of gene expression*.
Genes

Primers

Sequences (5’ - 3’)

Primer work Con. (nM)

Efficiency (%)

Dmn

Dmn F

GACAAGTTGAGCCGCCTTAC

300

98.5

Dmn R

CTTGGTGCTTAGATGACGCA

300

Ytr F

ATTTTGGACCAGCACCACTC

300

Ytr R

CAAAATCCCTGCAATTTCGT

300

LanB1 F

TCAACGAGCACCTGATTCAC

300

LanB1 R

GCAAATGGATGTTTCCCAAT

300

Xbp1 F

GGGAGAGCAACTTTGACGAG

300

Xbp1 R

GCCGGCCAAACTTAACAATA

300

Atp-a F

ACCCACACTGCTACACTCCC

300

Atp-a R

TCCTGGTTGCTCTTGTTGTG

300

Dip-B F

AGGATCACGCCAGAAGACTG

300

Dip-B R

AGTCACTGGGACGGAGAATG

300

CKII F

CCTGGTTCTGTGGACTTCGT

300

CKII R

GTAGTCCTCATCCACCTCGC

300

skpA F

CTAAAAGTCGACCAGGGCAC

300

skpA R

CCAGATAGTTCGCTGCCAAT

300

CG1702 F

GACATCTTTGCAGCCTGTGA

300

CG1702 R

GCCCTGATCTTGGGGTACTT

300

Ppv F

TTGACCACCCATGAACTCAA

300

Ppv R

GTGTTTGCTATGCTTGGGGT

300

Arc70 F

ATCGTACAACAACGAGCCCT

300

Arc70

CAGCGTGAAAGAAACGTCAA

300

cals F

AGTTTGTCAGCCCTCACCTT

500

cals R

CTCCTATGCATTGCGACAGA

500

Ephrin F

TTGCAATTCTTGGCATTCAC

300

Ephrin R

CATAGAGGTCGCGGTGATTT

300

plexA F

AAAGCAGCGATTGGCTTTTA

500

plexA R

GGCGCAGCTCTTATTCTGAC

500

plexB F

AACGGAACCACAAAAGATCG

300

plexB R

ATGTTACCGAGCGAACCAAC

300

Rad23 F

GCGGATAACGAAGACTTGGA

300

Rad23 R

TAGCCGTTCTATTGCGTCCT

300

Crk F

AACATTAATGGGCAATGGGA

300

Crk R

CATCGACAAATTCAACGTGC

300

unc-13 F

GCGTTGGACGACTTAGCTTC

300

unc-13 R

CATGTCTCCAAGTTCTCGCA

300

Ank F

TGCAGAGTTTGGCACTCATC

300

Ank R

TCGCCATCTTTTTCAATTCC

300

Mav F

GATAAAATCGACGAGGCCAA

300

Mav R

TTTTCCTAGATCCTGGCCCT

300

Ytr
LanB1
Xbp1
Atp-a
Dip-B
CKII
skpA
CG1702
Ppv
Arc70
cals
Ephrin
plexA
plexB
Rad23
Crk
unc-13
Ank
Mav

*Information from X. Deng dissertation.

90.6
94.5
97.1
106.3
92.8
98.4
90.4
92.7
94.2
86.4
89.2
95.2
86
98.8
99
92.6
99.9
100.1
104.4
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values for three biological replicates (each containing two technical replicates)
per genotype were averaged into one Ct value per gene (performed by Mx3000P
software, Stratagene). Statistical significance was assessed by performing an
unpaired two-tail t test. A total of 19 genes were selected from three different
gene groups (Autosomal, fourth chromosomal, and X chromosomal). The
selected genes were expressed at moderate levels, displayed uniform
absorbance in arrays of the same genotype, and reﬂected the average change in
expression for their gene group in roX1 roX2 males. The autosomal gene Dmn
was selected as a reliable transcript for expression normalization (data not
shown). The primers used in this study are presented in Table 2-2.

Gene expression microarrays
Total RNA was prepared from three groups of 50 third instar larvae of both
genotypes. Each RNA preparation served as a template for probe synthesis. A
total of six probes were made: three from female roX1 roX2 larvae, and three
from female roX1 roX2 larvae carrying the [w+Hsp83-roX1+] transgene. Probes
were synthesized at the ATGC core facility following manufacturer’s instructions
(www.Affymetrix.com). Hybridization of Affymetrix Drosophila Genome 2.0 chips
(Santa Clara, CA) was also performed at the core facility. Background corrected
intensity values were quantile normalized (Irizarry et al., 2003). In brief, all probe
intensities from mutant and control arrays were assembled into a single ranking.
Probes from individual chips were assigned the value of the corresponding
quantile, thus preserving the rank order within a chip and standardizing intensity
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distribution across all chips. Signal intensities were summarized into one
expression value per sample and probe set using the robust multi-array average
(RMA) algorithm. The Affymetrix MAS5.0 Present/Absent calls were used to ﬁlter
out probe sets not present in at least two out of three replicates of each genotype.
Genes and probe sets (Berkeley Drosophila Genome Project annotation
release 5.8) were sorted to enrich for heterochromatic genes on the basis of the
boundaries between heterochromatic and euchromatic regions (Hoskins et al.,
2007; Smith et al., 2007). The coordinates of these boundaries are: 2R;11285689,

2L;22000975-23011544,

3R;1-378656,

3L;22955576-24543557,

X;22030326-22422827. The coordinates for heterochromatin that is not
contiguous with assembled arm sequences are 2LHet;1-368872, 2RHet;13288761, 3LHet;1-2555491, 3RHet;1-2517507, XHet;1-204112, YHet; 1-347038.
Only probe sets assigned to a chromosome were used. Genes and probe sets
assigned to heterochromatic regions were obtained from FlyBase GBrowse. The
corresponding gene and probe set information was obtained from the Affymetrix
Drosophila_2 annotation ﬁle (Drosophila_2.na25) released on March 17, 2008
(Liu et al., 2007). Detailed microarray information is present in Appendix A.

Statistical methods and descriptions
The log2 fold change of each gene was computed as the log2 mean RMA
expression of mutant samples minus the log2 mean RMA expression of control
samples. The signiﬁcance of differences between groups was assessed by the
Wilcoxon test. Analyses were performed in the R software environment (www.r-
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project.org) using Bioconductor (www.bioconductor.org) (Gautier et al., 2004).
The raw data can be downloaded from the Gene Expression Omnibus (http://
www.ncbi.nlm.nih.gov/geo,GSE12076).
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RESULTS

Females do not require roX for full expression of genes in heterochromatic
environments
Simultaneous mutation of roX1 and roX2 is lethal for male adults, but
males mutated for only one roX gene are normal with full survival. A microarray
study conducted to compare genome wide expression in roX1 roX2 males (null
for roX function) and roX2 (control) males primarily showed a global decrease of
expression from the entire fourth chromosome, as well as X chromosome (Figure
2-2, A and B, (Deng et al., 2009; Deng and Meller, 2006)). The roX RNAs are
redundant for their effect on fourth-linked genes, as well as for dosage
compensation (Deng et al., 2009). The data that suggested a roX-dependent
fourth chromosome regulation is based on a study of male flies. However, the
idea that autosomal genes are regulated the same way in males and females is
more plausible. roX1 is abundant in early development stages of both sexes, and
thus might contribute to the expression of fourth-linked genes in both sexes
(Meller, 2003). Studies by our lab showed that MSL1, MSL3 and MLE are also
necessary for normal expression of fourth-linked genes in males. All MSL
proteins, except MSL2, which is not necessary for regulation of fourth-linked
genes, are also present in females (Deng et al., 2009; Rastelli et al., 1995). To
investigate the effect of loss of roX transcripts on expression of fourth-linked
genes in females, microarrays were performed to compare the genome wide
expression between roX1 roX2 and roX1 roX2; [w+Hsp83-roX1+] female larvae.
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Figure 2-2. Expression of the fourth chromosome is reduced in roX1 roX2
males but not in females. (A) In roX1SMC17A roX2 males the expression of
fourth-linked genes (blue) decreases in comparison with the rest of the genome
(gray). Points represent the log2 of the ratio of gene expression in roX1SMC17A
roX2 males to control males (roX2) plotted against expression level (log2
absorbance). There are 9880 non-fourth-linked genes and 74 fourth-linked genes
plotted. (B) The density distribution of log2 expression (mutant/control) for fourthlinked genes (blue) and second and third chromosome genes (gray) in males.
The distribution of fourth-linked genes differs signiﬁcantly from the remaining
autosomal genes (adjusted P-value 6.6X10-16; Wil-coxon test). (C) In roX1SMC17A
roX2 females the expression of fourth-linked genes (blue) is unchanged. The rest
of the genome is shown in gray. Data is presented as the log2 of the ratio of gene
expression in roX1SMC17A roX2 females to control females (roX1SMC17A roX2;
[w+Hsp83-roX1+]) plotted against expression level (log2 absorbance). Genes
contributing to this analysis are 8433 non-fourth-linked and 69 fourth-linked
genes. (D) The density distribution of log2 expression (mutant/control) for fourthlinked genes (blue) and second and third chromosome genes (gray) in female
larvae. The distribution of fourth-linked genes is not signiﬁcantly different from
that of the second and third chromosomes (adjusted P-value 0.92). Only genes
called as present in at least two out of three replicates were included. Microarray
data was analyzed by S. K. Koya and A. Tarca.
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This strategy enabled me to compare expression in roX1 roX2 females with
control females of virtually identical genetic background but carrying a roX1
transgene, which rescues male survival and expression of both X-linked and
fourth-linked genes of roX1 roX2 males (Meller, unpublished, (Deng et al., 2009)).
This minimizes inconsistency due to differences in genetic background. Two
different plots were used to show this data. In figure 2-2 C, every gene is
presented as a dot with expression level (X axis) plotted against log2 ratio of
expression change (mutant : control) on the Y axis. The range of expression
ratios is narrower in females than males (compare Figure 2-2, A and C). This is
consistent with the fact that females are not developmentally disrupted by
elimination of both roX RNAs. The expression of fourth-linked genes did not
change in roX1 roX2 females as compared to control females that express roX1
from the [w+Hsp83-roX1+] transgene (Figure 2-2 C). A plot of the log2 of the
expression ratio (mutant : control) of euchromatic genes on the second and third
chromosomes has a distribution centered near zero. In contrast, the distribution
of fourth-linked genes is shifted left in males (Figure 2-2 B), but is not signiﬁcantly
different from that of the second and third chromosomes in females (Figure 2-2
D). Therefore, the presence of the constitutively expressed roX1 transgene did
not affect expression of fourth-linked genes in roX1 roX2 females. Quantitative
RT-PCR of cDNAs from the same templates confirmed the microarray results
(Table 2-3). I conclude that roX RNA are only required for full expression of
fourth-linked genes in males.
The fourth chromosome is enriched for heterochromatin (reviewed in
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Table 2-3. Q-RT-PCR validation of microarray analysis
Genes

Microarray Average

Fold Change
∆Array
∆QPCR
(p-value)
(std. dev.)

Name

Chip_ID

Position

Mutant

Control

Xbp1

1635355

57C3-4

10.45

10.38

1.01
(0.41)

1.10
(0.13)

ytr

1623384

60A3

10.24

10.28

1.00
(0.68)

1.08
(0.22)

bigmax

1628490

97F1

9.42

9.32

1.01
(0.71)

1.00
(0.32)

skpA

1625801

1B14

12.04

12.04

1.00
(0.98)

0.98
(0.23)

Sgs4

1626630

3C10

14.06

13.98

1.01
(0.35)

1.09
(0.20)

plexB

1623432

102A1

7.92

7.85

1.01
(0.55)

1.05
(0.14)

Rad23

1625068

102B3

11.05

11.03

1.00
(0.85)

1.11
(0.15)

Crk

1634217

102A8

11.39

11.38

1.00
(0.95)

1.15
(0.16)

Ank

1635711

102A3

9.94

9.96

1.00
(0.91)

1.09
(0.16)

cals

1628842

102F8

10.15

10.16

1.00
(0.91)

1.10
(0.27)

To validate the microarray data of female roX1SMC17A roX2 flies, expression of
selected genes was examined by Q-RT-PCR. cDNA templates used for Q-RTPCR were generated from the same RNA samples used for microarray analysis.
For each genotype, three independent RNA samples were used. Two PCR
reactions per template were performed in parallel using an Mx3000P Realtime
PCR system (Stratagene). Dmn was used as the normalizing gene. The
microarray gene expression data was background corrected, normalized and
summarized into a one expression value per sample and probeset using the
RMA (robust multi-array average) algorithm. The microarray average is the
average of three samples per genotype. The p-value of microarray analysis is
generated by t-test. P-value > 0.2 means no significant changes.
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Figure 2-3. Genes situated in proximal heterochromatin require roX RNA for
full expression in males but not in females. (A) Genes in proximal
heterochromatin have reduced expression in roX1SMC17A roX2 male larvae. Box
plots were generated using the log2 expression ratios (mutant/control) presented
in Figure 2-2 A. The mean expression of genes in proximal heterochromatin on
the second and third chromosomes decreases by 0.17 in roX1SMC17A roX2 males
(adjusted P-value of 0.003). The mean expression of X-linked genes decreases
by 0.24, and expression of fourth-linked genes decreases by 0.58. Changes of
the X and fourth chromosome have an adjusted P-value of < 6.6X10-16. Only
genes called as present in at least 2 out of 3 arrays contributed to this analysis
(8347 in second and third euchromatin; 1533 in X euchromatin, 73 in second and
third heterochromatin, and 74 on the fourth chromosome). (B) fourth-linked and
heterochromatic genes do not require roX RNA for full expression in females.
Box plots were generated using the log2 expression ratios (mutant/control)
presented in Figure 2-2 C. The mean change in expression of X-linked genes in
roX1SMC17A roX2 females is -0.04. Second and third chromosome
heterochromatic genes and fourth-linked genes have a slight average increase
(0.06 and 0.01, respectively) that is not statistically signiﬁcant. Only genes called
as present in at least 2 out of 3 arrays contributed to this analysis (7097 in
second and third euchromatin, 1336 in X euchromatin, 57 in second and third
heterochromatin, and 69 on the fourth chromosome). Microarray data was
analyzed by S. K. Koya and A. Tarca.
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(Riddle and Elgin, 2006)). Genes located in heterochromatic regions are
presumed to have specialized regulatory features that enable their expression
from repressive heterochromatic environment (Yasuhara and Wakimoto, 2006). It
is possible that the involvement of roX RNAs in a general pathway to antagonize
heterochromatin accounts for fourth-linked regulation. Reanalysis of microarrays
showed that expression of heterochromatin-enriched genes on the second and
third chromosomes also require roX RNA (Figure 2-3 A, (Deng et al., 2009)).
Consistent with fourth-linked genes, expression of heterochromatic genes on the
second and third chromosomes remained unchanged in roX1 roX2 females
(Figure 2-3 B). This suggests that there is a male-limited regulatory system for
heterochromatic gene expression which involves roX RNAs.

A full length roX1 transgene does not fully rescue expression of autosomal
genes in males
roX RNAs are redundant for full expression of fourth-linked and
heterochromatic genes in males. To confirm that reduced expression in roX1
roX2 males is due to loss of the roX transcripts, the expression of fourth-linked
genes was examined in roX1SMC17A roX2 males carrying an autosomal roX1
transgene, [w+Hsp83-roX1+], which fully rescues both male survival and X
localization of the MSL proteins of roX1 roX2 males (Meller, unpublished).
Although this transgene rescues X-linked gene expression fully, only partial
restoration of fourth-linked gene expression was observed (PhD thesis, X. Deng).
As shown in figure 2-4, the expression level of X-linked genes from roX1SMC17A
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Figure 2-4. A full length roX1 transgene does not fully rescue autosomal
gene expression. (A) 5’ ends of roX1 transcript and transgenes. The top line
indicates the roX1 genomic region, numbering from (Amrein and Axel, 1997). The
bent arrow indicates a transcription start site. Two additional transcription start
sites are 306 and 675 bp downstream. roX1+ and roX1FULL (short for [w+hsp83roX1+] and [w+hsp83-roX1Full]) are illustrated below. The box represents hsp83
promoter. (B) Expression of fourth-linked genes is partially restored by roX1
transgenes. Five autosomal, three X-linked and 10 fourth-linked genes were
analyzed by Q-RT-PCR in roX1SMC17A roX2 (control), roX1SMC17A roX2; [w+hsp83roX1+] (black) and roX1SMC17A roX2; [w+hsp83-roX1Full] (gray) male larvae.
Expression from microarray analysis of roX1+ roX2- male larvae (white) is shown
for comparison. Error bars represent standard deviations from three independent
measurements. Q-RT-PCR was normalized to the autosomal gene Dmn.
Expression in roX1SMC17A roX2 males was set to 1.

47

roX2 males carrying this transgene is almost the same as roX2 single mutant.
However, the expression of fourth-linked genes is lower than that in the roX2
single mutant, but higher than that in the roX1SMC17A roX2 double mutant. The
roX1+ transgene contains almost all of roX1, only lacking 100 bp at the extreme 5’
end (Figure 2-4 A). Analysis of roX1 ESTs (Expressed Sequence Tag, Flybase)
showed that this 100 bp sequence is present in only a minor fraction of roX1
transcripts. This suggested that the 5’ end of roX1 may have a separate function
in the regulation of fourth chromosome or heterochromatic genes. To investigate
this possibility, a full length roX1 transgene including the additional 100 bp 5’
sequence, [w+Hsp83-roX1FULL], was created (Figure 2-4 A). roX1SMC17A roX2 flies
carrying this transgene were generated, and the expression of a panel of
euchromatic autosomal, fourth-linked and X-linked genes were measured by
quantitative RT-PCR. When compared to the expression of these genes in roX1
roX2 males carrying [w+Hsp83-roX1+], no significant difference in fourth-linked
gene expression could be detected (Figure 2-4 B). This suggests that the extra 5’
sequence is dispensable for regulation of autosomal genes. The incomplete
rescue by roX1 transgenes could be due to other aspects of the intrinsic roX1
gene. One possibility is that the regulation is achieved by cooperation between
different roX1 transcripts. Interestingly, [w+Hsp83-roX1FULL] rescue of X-linked
gene expression is also lower than that of [w+Hsp83-roX1+] (Figure 2-4 B). This is
consistent with the fact that the majority of roX1 transcripts do not contain this
extra 5’ sequences but still fully rescue X-linked genes expression.
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Investigation of candidate roX1 sequence that may limit roX1 regulation of
autosomal genes in females
The roX RNAs only affect expression of heterochromatic genes in males.
However, roX1 is present in both sexes in the early stages of development
(Meller, 2003). All MSL proteins, with the exception of MSL2, are maternally
provided to early embryos of both sexes (Rastelli et al., 1995). MSL2 is only
produced in the male zygote, limiting MSL complex formation to males (Rastelli
et al., 1995). While all other MSL proteins are required for heterochromatic
regulation, MSL2 is not necessary for full expression of heterochromatic genes
(Deng et al., 2009). What limits roX-dependent modulation of heterochromatin to
males is still mysterious. Sexlethal (SXL) is a candidate factor that might block
roX function in females. SXL is a multifunctional RNA-binding protein that
controls sexual differentiation in flies and is expected to regulate all sex-limited
processes directly or indirectly. The SXL protein is only expressed in females and
determines sexual development by modulating the expression of a set of
downstream genes including MSL2 (reviewed in (Salz and Erickson, 2010)). roX1
has two potential SXL binding sites in a small intron (Figure 2-5 A, (Meller et al.,
1997)). The function, if any, of these sites is unknown. It is possible that they bind
SXL in females, limiting the ability of rox1 to regulate heterochromatin. It is
anticipated that if SXL blocks up-regulation of heterochromatic genes in females
by binding to roX1, removal of SXL-binding sites from roX1 will result in an
elevated expression of heterochromatic genes in females. To test this possibility,
females with a roX1c20 transgene that lacks SXL binding sites were used. The
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Figure 2-5. Expression of fourth–linked genes is unchanged in females
expressing the roX1c20 transgene. (A) The roX1c20 transgene lacks SXL
binding sites and initiates at one of the major transcription start sites. The middle
line indicates the roX1 genomic region, numbering from (Amrein and Axel, 1997).
The arrow above represents the primiry roX1 transcript. Boxes represent SXL
binding sites. Below is the structure of the roX1c20 cDNA. roX1c20 lacks SXL
binding sites, present in a small intron, which has been spliced out. (B)
Quantitative reverse transcription PCR (Q-RT-PCR) of fourth-linked genes in
females. Two autosomal, three X-linked and six fourth-linked genes were
analyzed in female larvae carrying a hsp83-deiven roX1c20 transgene and in
control females. Values are the ratio of gene expression of transgenic females to
control (set to 1). Error bars represent standard deviations of at least three
independent measurements. Q-RT-PCR was normalized to the autosomal gene
Dmn. The full transgenic fly genotype is yw; [w+hsp83-roX1c20].
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roX1c20 transgene was made from a spliced cDNA that lacks the intron containing
SXL binding sites. It also initiates from a downstream transcription start site
(Figure 2-6A, (Stuckenholz et al., 2003)). We choose several fourth-linked genes
to test because of their heterchromatic features, and because these genes
appear very sensitive to loss of roX RNA in males. The expression of fourthlinked genes in female larvae was assessed by Q-RT-PCR. As shown in Figure
2-5 B, the expression of genes on fourth chromosome was unchanged. I
conclude that the SXL binding sites in roX1 do not limit roX1 function in females.
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DISCUSSION

roX RNAs participate in two distinct biological processes in flies: X
chromosome dosage compensation and normal heterochromatin function. Both
of these coordinately regulate large regions of the genome. Although all
molecules necessary for heterochromatin regulation are present in females, roX
RNA has no affect on heterochromatin in females. Therefore, roX-dependent
modulation of heterochromatin is limited to males, as dosage compensation.
Heterochromatin is present in both sexes, and autosomal heterochromatic
regions are present in two copies in both sexes. The male-speciﬁc involvement of
roX in heterochromatin function is an unexpected feature of heterochromatic
regulation. However, mutations in heterochromatin proteins do show sex-biased
phenotypes. Depletion of a major component of heterochromatin (HP1) causes
higher lethality and more gene misregulation in males (Liu et al., 2005). The
same study also identiﬁed differences in HP1 distribution in males and females.
These differences suggested that heterochromatin itself is different in males and
females. The male speciﬁc involvement of roX in heterochromatin function may
reflect the differences of heterochromatin content in the male and female
karyotypes.
Although roX-dependent regulation of heterochromatin is limited to males,
we could not exclude the possibility that there is a female-specific noncoding
RNA, rather than roX RNA, involved in the regulation of heterochromatin in
females. However, if a female-specific RNA is involved in regulation of hetero-
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chromatin, this represents a system different from the roX-dependent one that we
have described. Q-RT-PCR of several fourth-linked genes in mle mutants showed
that their expression was reduced in males, but unaffected in females (X. Deng,
dissertation). Therefore, at least one protein component of the roX-dependent
heterochromatin regulation system is necessary for normal expression of
heterochromatic genes in males, but not in females. This suggested that the
components of the roX-dependent heterochromatin regulation system do not
assemble with a female-specific RNA instead of roX RNA in females to modulate
heterochromatin.
Studies in our lab showed that heterochromatic genes display similar
expression in males and females (Deng et al., 2009). The fact that they are
differentially regulated in males and females, in spite of similar expression level,
raises the question of why this difference exists. One possibility is the Y
chromosome. The Drosophila Y chromosome represents 12% of the male
genome and is almost entirely heterochromatic. It absorbs a large portion of the
proteins that assemble into heterochromatin. Therefore, it affects other
heterochromatic regions in male genome. Loss of the Y chromosome frees these
proteins to enable them to bind elsewhere, promoting heterochromatin formation
and enhancing Position Effect Variegation (PEV) throughout the genome (Weiler
and Wakimoto, 1995). Therefore, loss of the Y chromosome silences transgenes
in proximal heterochromatin and on the fourth chromosome. Our studies show
that loss of roX RNAs increases expression from these transgenes (Deng et al.,
2009). roX and the

Y chromosome

thus exert

opposing effects on
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heterochromatic expression.
Therefore, the role of the newly discovered roX-dependent system in sexspeciﬁc

regulation

of

heterochromatin

may

accommodate

the

different

heterochromatin environment in males, which carry a large, heterochromatic Y
chromosome. Dosage compensation evolved in animals with differentiated X and
Y chromosomes to balance expression of X-linked genes. During the evolution of
sex chromosome pairs, the Y chromosome irreversibly loses coding sequences
and accumulates repetitive sequences (Rice, 1996). This process promotes the
formation of heterochromatin on the Y chromosome. The roX-dependent system
that we have identified may have evolved to resolve a problem raised by the
presence of a highly heterochromatic Y chromosome in the male nucleus. The Y
chromosome

changes

the

chromatin

environment

in

the

nucleus,

as

demonstrated by its influence on PEV. It is possible that the roX-dependent
process arose to accommodate this difference in chromatin environment. Both
processes

of

roX-dependent

dosage

compensation

and

modulation

of

heterochromatin occur only in males. They may have evolved to accommodate
two different problems resulting from sex chromosome differentiation.
The molecular basis of roX regulation of heterochromatic genes is
currently unclear. MSL1, MSL3 and MLE, but not MSL2, the only factor limited to
males, are necessary for full expression of heterochromatic genes in males
(Deng et al., 2009). roX1 is present in females in the early stages of development
(Meller, 2003). In contrast, roX2 expression is limited to males. MSL1, MSL3 and
MLE are also stably present in early embryos and in females (Rastelli et al.,
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1995). It is possible that roX RNA, MSL1, MSL3 and MLE associate to form a
complex that plays a transient role in the initial formation of heterochromatin in
early embryos. However, what prevents this from occurring in females is still
unclear. My study suggests that SXL binding to roX1 is not the mechanism that
prevents roX1 activity in females. However, there may be other sex-limited
factors that block regulation of heterochromatin in females, or enable it in males.
roX1 has several regions important for dosage compensation. The 5’
region of roX1 is important for MSL localization and a 3’ stem-loop is essential for
the chromatin modification by MSL (Deng et al., 2005; Park et al., 2008;
Stuckenholz et al., 2003) It is possible that there are roX1 regions that participate
in regulation of heterochromatic genes, but not in dosage compensation. One
candidate roX1 region suggested by our preliminary data was the extreme 5' end,
a region that is absent from most of the roX1 transcripts produced by the fly (S. K.
Koya, unpublished). As my full length roX1 transgene including this region was
not more active in rescue of heterochromatic genes compared to a transgene
without this region but otherwise identical, I conclude that this region is
dispensable for regulation of heterochromatic genes. The incomplete rescue by
the full length roX1 transgene could be due to some aspects of the intrinsic roX1
gene. There is mixture of different roX1 transcripts that are regulated by choice of
transcription start sites, alternative splicing and transcript stability in the wild type
flies. One possibility is that the regulation of heterochromatin is achieved by
cooperation between different roX1 transcripts.
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CHAPTER 3

NONCODING roX1 RNA 5’ SEQUENCES CONTRIBUTE TO X CHROMOSOME
LOCALIZATION AND LOCAL SPREADING OF THE MSL COMPLEX

This chapter is organized as manuscript in preparation (Kong Y. et al., in
preparation)

INTRODUCTION

Transcriptional regulation in eukaryotes involves a large number of noncoding RNAs of various sizes. Previous studies show that they play critical roles
in gene regulation through multiple mechanisms, including DNA methylation,
chromatin modification, gene silencing, and dosage compensation (reviewed in
(Mattick, 2003; Mattick and Makunin, 2005)). It is suggested that non-coding
RNAs played a crucial evolutionary role by increasing the complexity and
regulation of gene expression (reviewed in (Mattick, 2003; Prasanth and Spector,
2007)). Several long non-coding RNAs are misregulated in various diseases
(Gupta et al., 2010; Prasanth and Spector, 2007; Taft et al., 2010). While an
increasing number of long non-coding RNAs that have important functions has
been discovered, the mechanisms by which they act are poorly understood
(reviewed in (Mercer et al., 2009)). roX1 is a long non-coding RNA involved in the
epigenetic regulation of the X chromosome during dosage compensation in
Drosophila. Functional dissection of roX1 will contribute to our understanding of
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other long non-coding RNA involved epigenetic processes, including those
involved in human diseases.
Dosage compensation is a chromatin-mediated process that maintains a
constant ratio of X-linked and autosomal gene expression in males and females
(reviewed in (Lucchesi et al., 2005)). In Drosophila, dosage compensation occurs
by a two-fold up-regulation of transcription from the single male X chromosome
to match the transcription from the two female X chromosomes (reviewed in
(Kong and Meller, 2007)). Dosage compensation in Drosophila is mediated by
the Male-Specific Lethal (MSL) complex. The MSL complex specifically binds the
male X chromosome and directs acetylation of histone H4 at lysine 16 (H4K16ac)
(Bone et al., 1994; Smith et al., 2000). MSL localization along the male X is
discontinuous. The MSL complex binds preferentially to actively transcribed
genes, and is especially enriched within 3’ transcribed regions (Alekseyenko et
al., 2006; Gilfillan et al., 2006). Little MSL complex binds silent genes or
intergenic regions of the X.
The MSL complex is composed of five Male-Specific Lethal (MSL)
proteins and two non-coding roX (RNA on the X) RNAs. The five MSL proteins
are MSL1 (Male-Specific Lethal 1), MSL2 (Male-Specific Lethal 2), MSL3 (MaleSpecific Lethal 3), MLE (Maleless) and MOF (Males Absent on First) (reviewed in
(Kong and Meller, 2007)). MSL1 is proposed to serve as the scaffold for
assembly of the MSL complex (Li et al., 2005). MSL2 is a RING finger protein
that regulates assembly of the complex, has DNA binding activity, and is only
expressed in males (Fauth et al., 2010; Kelley et al., 1995). Recently it was found
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to be an E3 ubiquitin ligase that modifies histone H2B on lysine 34 (Wu et al.,
2011). The role of this activity in dosage compensation remains unknown. MSL3
contains a chromodomain that recognizes the cotranscriptional histone H3
trimethylation

mark

H3K36me3

(Larschan

et

al.,

2007).

The

MSL3

chromodomain is required for the enrichment of the MSL complex within
transcribed genes, and explains why the complex is specifically localized within
the bodies of active genes (Sural et al., 2008). MOF is a histone
acetyltransferase which acetylates histone H4 at lysine 16 (Hilfiker et al., 1997).
MLE is an ATP-dependent DexH RNA/DNA helicase (Lee et al., 1997). The
ATPase activity is necessary for transcriptional enhancement by the MSL
complex (Morra et al., 2008). The helicase activity of MLE is essential for normal
localization of the MSL complex on the X chromosome, and for movement of the
roX RNAs from their sites of synthesis (Gu et al., 2000; Meller et al., 2000; Morra
et al., 2008). MLE is suggested to associate with the MSL complex through an
RNA (Richter et al., 1996; Smith et al., 2000). However, a recent study suggests
that MLE is also capable of direct interaction with MSL2 (Morra et al., 2011). The
stability of roX1 is particularly dependent on MLE, supporting the idea of a direct
interaction between these molecules (Meller, 2003). X-localization of remaining
complex members is reduced or absent in males missing any one of the MSL
proteins, or in males mutated for both roX genes. The mechanisms that underlie
targeting of the MSL complex to the male X chromosome are poorly understood.
A two-step model is proposed for MSL complex targeting to X
chromosome (reviewed in (Gelbart and Kuroda, 2009). In this model, the MSL
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complex specifically recognizes and binds to a number of X-linked sites called
chromatin entry sites (CES), also known as High Affinity Sites (HAS). These are
regions that retain residual MSL binding in an msl3 mutant background
(Alekseyenko et al., 2008; Straub et al., 2008). ChIP-chip and ChIP-seq studies
have identified over one hundred CESs on the X chromosome (Alekseyenko et
al., 2008; Straub et al., 2008). Binding to CES sites is postulated to depend on
interaction of the MSL complex with DNA sequences. After binding to the CES,
the MSL complex is thought to spread to nearby, transcribed genes in a
sequence-independent manner. This local spreading is partly mediated by the
recognition of the H3K36me3 mark by the MSL3 chromodomain (Larschan et al.,
2007; Sural et al., 2008). Other features, such as lower affinity binding sites that
act cooperatively with the CES to recruit MSL complex and interphase
chromosome architecture, which may bring X-linked sequences close together,
could also contribute to MSL localization on X (Gilfillan et al., 2007; Grimaud and
Becker, 2009; Kotlikova et al., 2006).
roX RNAs are also required for the localization of the MSL complex to the
male X chromosome (Deng et al., 2005; Meller and Rattner, 2002). Upon
elimination of both roX transcripts, mislocalization of the MSL proteins to
heterochromatic regions and autosomal sites is observed (Deng et al., 2005).
This is accompanied by a global decrease of X-linked gene expression (Deng
and Meller, 2006). roX RNAs are male-preferential (roX1) or male-specific (roX2)
non-coding RNAs that are transcribed from the X chromosome and assemble
with the MSL proteins to coat the X chromosome (Amrein and Axel, 1997; Meller
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et al., 1997). roX1 and roX2 are functionally redundant, in spite of a lack of
extensive sequence similarity (Meller and Rattner, 2002). Assembly of roX RNAs
into the MSL complex stabilizes the RNA, since they are rapidly degraded in the
absence of MSL proteins (Meller et al., 2000).
The roX RNAs appear to direct MSL complex localization by two
genetically distinct mechanisms. roX RNA is normally transcribed from the X
chromosome, but autosomal roX transgenes enable the MSL complex to bind the
X chromosome and rescue roX1 roX2 males (Meller and Rattner, 2002). The roX
RNAs can thus act when they originate in trans to the chromosome that they
modify. The roX RNAs can also direct the spreading of the MSL complex into
chromatin flanking autosomal sites of roX RNA synthesis in flies carrying a roX
transgene (Kelley et al., 1999). Autosomal spreading is discontinuous, which is
similar to the spreading pattern on the X, suggesting that this spreading occurs
by a mechanism similar to spreading on the X chromosome (Kelley et al., 1999).
This was confirmed by ChIP studies that detected enrichment of MSL3 and
H4K16ac in genes flanking an autosomal roX1 insertion (Park et al., 2010). The
mechanism of spreading of MSL complex from a site of roX transcription into
flanking chromatin is unknown, but one model to explain local spreading
proposes that it is controlled by MSL complex assembly on nascent roX
transcripts. If assembly of the complex is complete before the roX transcript is
released from the DNA template, the MSL complex will then bind chromatin
immediately, localizing in the vicinity of the roX genes (Oh et al., 2003; Park et al.,
2002). However, if MSL protein is limiting, or roX transcription is fast, formation of
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the intact complex will occur in the nucleoplasm after release of roX RNA from
the chromatin template. The complex will then be able to travel to sites far from
roX transcription. While unproven, this idea is supported by studies in which the
level of MSL proteins or roX RNA has been manipulated. A high ratio of MSL
proteins to roX transcripts promotes local spreading from sites of roX
transcription, but when roX transcripts are more abundant, local spreading is less
likely to occur (Kelley et al., 2008; Oh et al., 2003; Park et al., 2002).
A similar, RNA-dependent process occurs in mammalian females during X
inactivation. The X inactive specific transcript (Xist) RNA is a large, non-coding
transcript that is central to dosage compensation in mammals. Xist is transcribed
from the Xic (X inactivation center) and coats the entire inactive X chromosome
(Jaenisch et al., 1998). Xist sequences required for silencing and localization
have been identified. A 5’ repeat element (repeat A) that can form a two stemloop structure is essential for X chromosome silencing, while redundant, spatially
separated sequences throughout Xist act co-operatively to promote Xist
localization to the X (Wutz, 2003).
We postulated that roX1 might be similarly organized into regions with
distinct function. The major roX1 transcript is 3.7 kb (Amrein and Axel, 1997;
Meller et al., 1997). It contains redundant 3’ ‘roX boxes’, which may form
alternative

secondary

structures

and

are

necessary

for

the

histone

acetyltransferase activity of the MSL complex (Kelley et al., 2008; Park et al.,
2008). The ‘roX box’ is the only highly conserved element between roX1 and
roX2, and between roX genes in different species (Park et al., 2008). A small 3’
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stem loop incorporating one of these roX boxes was the first functional element
identified in roX1 (Stuckenholz et al., 2003). The 5’ end of roX1 also contains
sequences that are necessary for function. Deletion of the entire 5’ end destroys
roX1 activity, but small (<300 bp) deletions scanning across the 5’ end do not
detectably influence the activity of roX transgenes (Stuckenholz et al., 2003).
However, loss of large amounts of 5’ sequences has a particularly strong effect
on MSL localization (Deng et al., 2005). roX1 transcripts thus appear to contain
distinct domains for X localization and chromatin modification, as does Xist. And,
like Xist, the internal roX1 sequence between the 5’ and 3’ ends is not essential
for function. We hypothesize that, like Xist, multiple redundant elements that
contribute to X chromosome targeting might be distributed throughout the 1.5kb
sequence at the 5’ end of the roX1 transcript.
In this study, roX1 transgenes containing different sections of the 5’ end
were created and analyzed to investigate the function of this region. This study
demonstrated that multiple redundant elements contributing to X chromosome
targeting are present throughout the 5’ end of roX1. I also demonstrated that the
extreme 5’ end of roX1 has a unique function that promotes MSL complex
spreading in cis from sites of roX production. Intriguingly, roX1 has multiple
transcription start sites that are developmentally regulated. Spreading in cis is
promoted by a portion of roX1 that is present in few naturally occurring roX1
transcripts, suggesting that production of roX RNA capable of directing spreading
in cis is tightly controlled by the cell. It also suggests that roX1 activities are
regulated by choice of transcription start site. My studies reveal that while all 5’
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regions tested can recruit MSL1 to the X chromosome, one region is deficient in
recruitment of MLE. This suggests that different 5’ segments make different
molecular contacts within the MSL complex. Finally, I demonstrate that while all
of my transgenes are able to partially restore the viability of roX1 roX2 males
when transcribed from an autosome, one of them is specifically deficient in male
rescue when transcribed from X-linked sites. I anticipate that future studies of this
unexpected finding may explain how the roX genes direct chromatin modification
in cis to sites of transcription.
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Materials and Methods

Drosophila strains
Flies were maintained in vials containing standard cornmeal agar media at
25°C. The roX1mb710, roX1ex40A and roX1SMC17A mutations have been previously
described (Deng et al., 2005; Meller et al., 1997). Df(1)52 is a lethal deletion of
roX2 and essential ﬂanking genes. Elimination of roX2 is accomplished by
complementing Df(1)52 with [w+4∆4.3], a cosmid insertion carrying essential
deleted genes but lacking roX2 (Meller and Rattner, 2002). For convenience this
combination is referred to as roX2. y w; P[y+CaryattP]2, which contains
P[y+CaryattP] at 68A4, was obtained from the Bloomington Drosophila stock
center (BDSC stock# 8622). The roX1 transgene, [w+hsp83-roX1+], is a hsp83driven roX1 genomic fragment (roX1 bp 42-4165, numbering from Amrein and
Axel, 1997). The roX1 transgene, [w+hsp83-roX1FULL], is described in chapter 2.
The mutations in msl1L60, msl32 and mle1 have been previously described
(Chang and Kuroda, 1998; Lindsley and Zimm, 1992). The msl2 transgene,
[w+hsp83-M2]6I, has also been described previously (Kelley et al., 1995).

Generation of roX1 deleted transgenes for site-specific integration
Three roX1 transgenes containing different 5’ fragments and the essential
3’

region,

[w+hsp83-roX1R1],

[w+hsp83-roX1R2],

[w+hsp83-roX1R3],

were

generated. These are named as [w+hsp83-roX1R1-3]. For convenience these are
also referred to as roX1R1-3. The roX1R2 transgene was created by PCR
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amplification

of

genomic

sequence

from

the

roX1ex40A

mutant

using

oligonucleotides roX1 190F and roX1 R4150 (Deng et al., 2005). roX1ex40A
mutation has an internal deletion of roX1 bp 809-3150. The roX1R1 and roX1R3
transgenes were generated by joining roX1 5’ fragments (bp -85-310 and 7901490) to the 3’ sequence present in roX1ex40A (bp 3150-4150). In brief, the roX1 5’
fragments and 3’ sequence were amplified separately by PCR from wild type
genomic template using oligonucleotides roX1 -85F and roX1 310R (roX1R1 5’
fragments), roX1 790F and roX1 1490 R (roX1R3 5’ fragments), roX1 3150F and
roX1 R4150 (3’ fragments). A XhoI site is introduced by the reverse primer of 5’
fragment and the forward primer of 3’ fragment. The 5’ and 3’ roX1 fragments
were then cut with XhoI and ligated together, and then subcloned into pCR4TOPO vector (Invitrogen). After amplification of the plasmid, the roX1R1, roX1R2
and roX1R3 fragments were released from pCR4-TOPO by EcoRI and ligated into
a modified pUASTB. pUASTB is a transformation vector carrying an attB site and
a mini-white gene (Groth et al., 2004). pUASTB was modified by introducing the
strong and constitutive hsp83 promoter. The hsp83 promoter was amplified from
the pCasper HS83T3 vector (Meller et al., 2000) by PCR using oligonucleotides
hsp83 Link F and hsp83 Link R. A KpnI site was introduced at the forward primer
hsp83 Link F and BamHI, EcoRI and SacII sites were introduced at the reverse
primer hsp83 Link R. A KpnI-SacII fragment containing the hsp83 promoter was
subcloned in the pUASTB. The unique BamHI and EcoRI sites were used to
clone roX1 adjacent to the promoter. Primers used to create roX1 transgenes are
listed in Table 3-1. To confirm correct cloning, the primers listed in Table 3-2 were
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Table 3-1. Primers used for creation of roX1 transgenes.
Primers

Sequences (5’ – 3’)

roX1 -85F

ATGTGCAATGCATGTATAACAGAAA

roX1 310R

ATCACTCGAGGGCAGGCCCTGGTAACTA

roX1 190F

AAGACATGGGCGTAGTTTCATATAC

roX1 790F

CTGATAGGGTGACCTAACGCAACAG

roX1 1490R

TACACTCGAGTCGATGCGTCGTTTATTG

roX1 3150F

TAGTCTCGAGCCAACCCCACATCAGGCC

roX1 R4150

ATCGAACTGTATATAATAATGGCATCAG

hsp83 Link F

ATGGTACCGATGATCCTTAACGGGGAACTTG

hsp83 Link R

AGCCGCGGGAATTCGGATCCTCGACGGTATCGATAAGCTAG
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Table 3-2.
Primers used for comfirmation of roX1 transgenes and
verification of integration of roX1 transgenes and recombinant
chromosomes.
Genotype or
integration site

Primer pairs

Seqences

[roX1R1] a

hsp83 662F

TTCGGACCACTTAGACGAATTT

roX1 BPR02

GAGGGTACCGGGACAGCTCGTATATGA

hsp83 662F

TTCGGACCACTTAGACGAATTT

roX1 557R

GTTTTTCTATTGTCCGGACTCG

hsp83 662F

TTCGGACCACTTAGACGAATTT

[roX1R2] a

[roX1R3] a

roX1SMC17A b

68A4 / 16C1 c

roX1 R5

ATATGGGGCTCATCCACTCC

7BXbal

GCTCTAGAATTCCAGTGATCGATCGGTAATAGTAAA

lacZ 5’ R

CCAGTCACGACGTTGTAA

y1456F

GGTCCACCGTTATATACGAAACA

BPR08wh
2A3 d

19C4 e

roX1 BPR25

Product
length (bp)
600

600

600

350

1750

TAGCTCCTGATCCTCTTG
GAGGTCTAGAGCTGGCAAACGACCTGAGCAATACT

ZH2A-3’

GTTACAAACAAGAGCCCAGCC

attL.For

GGGCGTGCCCTTGAGTTCTCTC

19C4.Rev

GACCATCCAACTTCCAACATCG

700

700

a To confirm correct structure of roX1R1-3 transgene, indicated primers that only
produce a fragment of the correct size when correct transgene is subcloned after
the hsp83 promoter, were used to amplify sequences from the hsp83 promoter
and linked roX1 transgene.
b To confirm the presence of roX1SMC17A mutation, indicated primers were used to
amplify sequences from roX1 genomic region and inserted P element.
c To confirm the integration of roX1R1-3 transgenes at 68A4 and 16C1, indicated
primers were used to amplify sequences from yellow gene and linked white gene.
yellow and white genes are close together after correct integration.
d To confirm the integration of roX1R1-3 transgenes at 2A3, indicated primers
were used to amplify sequences from roX1R1-3 transgene and the genomic region
proximal to the integration site.
e To confirm the integration of roX1R1-3 transgenes at 19C4, indicated primers
were used to amplify sequences from attL formed by integration and the genomic
region proximal to the integration site.
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used.

Generation of transgenic flies
The roX1R1-3 transgenes were integrated at 2A3, 16C1, 18D3 and 19C4
on the X chromosome and at 68A4 on the third chromosome using the sitespecific C31 integrase system (Groth et al., 2004). Stocks with an insertion of
an attP landing site in the P[y+CaryattP] P element at 68A4 were obtained from
the Bloomington Drosophila stock center. Mobilization of this P element was
accomplished by introducing a transposase source (TMS, Sb P[ry+t7.2∆2-3]99B)
and selecting for insertions on the X chromosome (P. Frolov, unpublished). The
exact location of the 16C1 and 18D3 insertions was determined by inverse PCR
and sequencing (Inverse PCR Protocol available from Berkeley Drosophila
Genome Project; http://www.fruitfly.org/about/methods/inverse.pcr.html). All of my
constructs were purified using Qiagen Plasmid Midi Kit (Qiagen). To generate
transgenic flies, I injected my constructs into Drosophila embryos derived from
mating female virgins carrying P[y+CaryattP] at 68A4, 16C1 and 18D3 with males
carrying a C31 integrase transgene on the 3rd chromosome. Adult flies derived
from injected embryos were mated to yw, and transgenics expressing the miniwhite marker were identified in their offspring. Transgenics were made
homozygous, and integration of the transgenes was verified by single fly PCR
using primers in the pUASTB transgene (BPR08wh) and P[y+CaryattP] target site
(y1456F) (Table 3-2). The roX1 transgenes inserted at 2A3 on the X
chromosome were generated by injecting my constructs into M[vas-int.Dm]ZH-
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102D, M[3xP3-RFP.attP]ZH-2A fly embryos by Rainbow Transgenic Flies, Inc
(3251 Corte Malpaso, Suite 506, Camarillo, CA 93012 USA). The roX1
transgenes inserted at 19C4 on the X chromosome were generated by injecting
my constructs into embryos derived from mating female virgins carrying
P[y+CaryattP] at 19C4 with males having a C31 integrase transgene at 2A3,
performed by BestGene, Inc (2918 Rustic Bridge, Chino Hills, CA 91709 USA).
The identification of integrants and verification was performed as described
above using primers in the pUASTB transgene (roX1 BPR25) and flanking
genomic region (ZH2A-3’ for site 2A3, 19C4.Rev for site 19C4).

Phenotypic testing of roX1 transgenes and rescue efficiency
All transgenes were analyzed in a roX1 roX2 double mutant background.
To analyze autosomal roX1R1-3 transgenes, roX1SMC17A Df(1)52; [w+4Δ4.3] female
virgins were mated with yw/Y; [w +hsp83-roX1R1-3 ] males to produce sons.
Survival of these sons was calculated based on the recovery of females from the
same cross. Survival of females (roX1SMC17A Df(1)52/yw; [w+4Δ4.3]/+; [w+hsp83roX1R1-3]/+) is set at 100%. To analyze X-linked roX1R1-3 transgenes, each was
recombined onto a roX1 SMC17A Df(1)52 chromosome to produce roX1SMC17A
Df(1)52 [w +hsp83-roX1 R1-3 ] chromosomes. These were maintained over a
Binsincy balancer (Figure 3-1). The survival of males carrying roX1SMC17A Df(1)52
[w+hsp83-roX1R1-3] X chromosomes was determined by mating females to males
carrying an autosomal insertion of [w+4∆4.3]. Male survival was calculated using
all male and female non-Binsincy offspring from the cross. These offspring carry
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Figure 3-1. The crossing scheme for recombining X-linked roX1R1, roX1R2
and roX1R3 transgenes onto a roX1 roX2 chromosome. The full genotype of
the roX1 roX2 chromosome is roX1SMC17A Df(1)52. Df(1)52 is complemented with
a cosmid which contains essential genes deleted by Df(1)52 but lacks roX2,
[w+4∆4.3]. For simplicity, this combination is referred to as roX2. X represents
mating.
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the roX1SMC17A Df(1)52 [w+hsp83-roX1R1-3] X chromosome.

Rescue of roX1SMC17A Df(1)52 [w+hsp83-roX1R1-3] males with msl mutations
and roX1 transgenes
To determine if roX1SMC17A Df(1)52 [w+hsp83-roX1R1-3]

males could be

rescued by reduction of MSL protein levels or overexpression of MSL proteins
and roX1, the mutations msl1L60, msl32 and mle1 (Chang and Kuroda, 1998;
Lindsley and Zimm, 1992), a third chromosome carrying both the [w+hsp83-M1]
and [w+hsp83-M2] transgenes (for convenience this chromosome is denoted as
[M1][M2], (Chang and Kuroda, 1998)) and autosomal roX1 transgenes roX1Full,
roX1R1-3 were used. roX1Full is

described in chapter 2. roX1SMC17A Df(1)52

[w+hsp83-roX1R1-3]/Binsincy; [w+4Δ4.3] female virgins were mated with w/Y;
msl1/[w+], w/Y; msl3/[w+], w/Y; mle/[w+], w/Y; [M1][M2]/+, yw/Y; [w+hsp83-roX1R13

] and yw/Y; [w+hsp83-roX1Full] males to produce roX1SMC17A Df(1)52 [w+hsp83-

roX1R1-3]; [w+4Δ4.3] /+ sons with reduced level of MSL protein or elevated MSL
protein or roX1. Male survival was determined as described above.

Extraction of genomic DNA from a single fly
A single fly is homogenized in an Eppendorf tube with a pestle in 50 µl of
squash buffer (10mM Tris-HCl pH8.2, 1mM EDTA, 25mM NaCl, 0.2mg/ml
proteinase K). The homogenate is incubated at 42°C for 1.5 hours, followed by
95°C for 10 minutes. 1.5 µl of this preparation is used as template for PCR
amplification.
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Polytene chromosome immunostaining
MSL1, MSL2 and MLE immunohistochemical detection on polytene
chromosomes was performed as previously described (Kelley et al., 1999). In
brief, polytene chromosome spreads were prepared from salivary glands of third
instar male larvae. Immunostaining was performed with MSL1, MSL2 or MLE
antibody (raised in rabbit) and detected with Texas Red conjugated α-rabbit
antibody. Slides were briefly dipped in Hoechst (0.1µg/mL) to visualize DNA
before mounting in 80% glycerol.

Photography
Observation and photography of immuno-histological images was
performed with a Zeiss Axioscope 2 fluorescent compound microscope fitted with
a Q-Imaging Retiga 2000R digital camera.

Generation and analysis of Beadex ﬂies
To analyze the level of dosage compensation, flies carrying a dose
sensitive Beadex allele (Bxr49k) on X the chromosome were used. roX2∆ is a
viable roX2 deletion mutation generated by FLP/FRT recombination (V. Meller,
unpublished). The roX1mb710 roX2∆ Dp(1;Y) Bxr49k X chromosome was made by
recombination and maintained over a Binsincy balancer. roX1mb710 roX2∆ Dp(1;Y)
Bxr49k/ Binsincy females were mated to yw; [w+hsp83-roX1R1-3] males to generate
roX1mb710 roX2∆ Dp(1;Y)Bxr49k/Y; [w+hsp83-roX1R1-3]/+ sons. Wings were
removed from flies, mounted in 4:5 lactic acid : ethanol and photographed. Wings

72

were measured and analyzed as previously described (Menon and Meller, 2009).
Briefly, the length of wing margin lost from anterior and posterior edges and vein
L3 length between the L2 junction and the edge of the wing were measured
using ImageJ software (http://rsb.info.nih.gov/ij/). The wing notching is expressed
as a ratio of the length of marginal lost to the length of the L3 vein to normalize
for variation in wing size. The signiﬁcance of differences in notching was
determined by performing an ANOVA test.

Total RNA isolation
Total RNA was extracted from three groups of fifty third instar larvae of
each genotype using TRIzol (Invitrogen). Briefly, fifty third instar male larvae
isolated based on gonadal morphology were homogenized in 1ml of TRIzol by
Tissue Tearor (Model 985-370, Biospec Products, Inc.). After centrifugation at
12000 rpm for 12 minutes, the supernatant was transferred into a new tube,
mixed with 0.2ml chloroform and centrifuged again at 12000 rpm for 15 minutes.
The aqueous phase was transferred into a new tube. Total RNA was precipitated
by adding 0.5ml of isopropanol to the aqueous phase. The RNA pellet was
washed with 75% ethanol, air dried, and dissolved in 50 µl RNase-free water.
Total RNA was then purified using the RNeasy Mini Kit following instructions
(Qiagen).

Quantitative-RT-PCR
Expression of roX1 and the X-linked genes Dlmo, SkpA, and Ck-II was
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Table 3-3. Primers used to analyze gene expression by Q-RT-PCR.
Genes

Primers

Sequences (5’ - 3’)

Primer work Con. (nM)

Efficiency (%)

Dmn

Dmn F

GACAAGTTGAGCCGCCTTAC

300

98.5

Dmn R

CTTGGTGCTTAGATGACGCA

300

CKII F

CCTGGTTCTGTGGACTTCGT

300

CKII R

GTAGTCCTCATCCACCTCGC

300

skpA F

CTAAAAGTCGACCAGGGCAC

300

skpA R

CCAGATAGTTCGCTGCCAAT

300

Dlmo F

TGAGATTGTTTGGCAACACG

500

Dlmo R

ACGCATCACCATCTCGAAG

500

roX1 F3377

TTTTGTCCCACCCGAATAAC

300

roX1 R3448

CCTTTTAATGCGTTTTCCGA

300

CKII

skpA

Dlmo

roX1

98.4

90.4

95.3

107.3
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measured by Quantitative-RT-PCR (Q-RT-PCR) as previously described (Deng
et al., 2005). Briefly, one microgram of total RNA was reverse transcribed at
42 °C for 1 hour using random hexamers and ImProm-II reverse transcriptase
(Promega). The reverse transcription reaction consisted of 1 µg RNA template,
0.5 µg random hexamers (primers), 3 mM MgCl2, 0.5 mM dNTP mix, 0.5 µl
Recombinant RNasin (RNase inhibitor), 1 µl ImProm-II reverse transcriptase
(Promega) and 4 µl 5XImProm-II reaction buffer in a total volume of 20 µl. The
quantitative PCR was performed using an Mx3000P Realtime PCR system
(Stratagene). Two PCR reactions for each template were performed in parallel.
Each PCR reaction consisted of 5 µl cDNA template (1:20 dilution), 0.3 µM of
each primer, and 12.5 µl 2XSYBR Green PCR Master Mix (Applied Biosystem) in
a total volume of 25 µl. Q-RT–PCR data were analyzed by the efficiency
corrected comparative quantiﬁcation method (Pfaffl, 2001). Ct values for three
biological replicates (each containing two technical replicates) per genotype were
averaged into one Ct value per gene (performed by Mx3000P software,
Stratagene). The selected X-linked genes are all down regulated in roX1 roX2
mutant (Deng and Meller, 2006). The autosomal gene Dmn was selected as a
reliable transcript for expression normalization (data not shown). The primers
used in this study are presented in Table 3-3. The significance of differences
attributable to different roX1 transgenes was determined by performing an
unpaired two-tail t-test.
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RESULTS

Deleted roX1 transgenes partially rescue roX1 roX2 males.
To investigate the function of 5’ roX1 sequence, three transgenes,
[w+hsp83-roX1R1], [w+hsp83-roX1R2] and [w+hsp83-roX1R3] (also referred as
roX1R1-3 for convenience), containing fragments of the roX1 5’ end were created.
Design of these roX1 transgenes was based on previous studies of roX1 mutants
and transgenes (Figure 3-2, (Deng et al., 2005) and data unpublished). These
studies indicated that activity was present in at least three regions in the 5’ end of
roX1. The first region, present in roX1R1, reflects the portion of the 5' end retained
in the roX1ex7B mutant, which retains partial roX activity. The second region,
present in roX1R2, when combined with the region present in roX1R1 and the 3’
functional sequence, supports full male viability. This is reflected by the survival
of roX1ex40A roX2 males (Figure 3-2). The third region, present in roX1R3, can be
deleted from roX1 without any phenotype (Deng et al., 2005). But the activity of
this region could not be excluded. roX1 transcripts from a major transcription
start site contain this region but lack region 1 and most of region 2. Possible
redundancy of region 3 with the other two regions is therefore likely. These 5’
fragments (roX1R1, bp -85–310; roX1R2, bp 190–805; roX1R3, bp 790–1490 of
roX1 (numbering from (Amrein and Axel, 1997)) were fused to the 3' fragment (bp
3150–4150) that contains the essential stem loop, roX boxes and roX1
termination signals (Figure 3-2). The sufficiency of this 3’ fragment is implied by
the survival of roX1ex40A roX2 males (Figure 3-2). In order to drive uniform
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Figure 3-2. Schematic structure of the roX1 gene and roX1R1, roX1R2 and
roX1R3 transgenes. Alignment of roX1R1, roX1R2 and roX1R3 sequences shows
the 5' fragments that were fused to the essential 3' end. Break points of selected
excision mutations that contributed to the design of these roX1 transgenes are
shown below. The top line indicates the roX1 genomic region, numbering from
(Amrein and Axel, 1997). The arrows above are: A. The start sites of a minor
class of roX1 ESTs (expressed sequence tags) at -47 bp. B. A popular roX1
transcription start site at 259 bp. C. The transcription start site of a major roX1
transcript at 628 bp. D. the site of the roX1mb710 P-element insertion. E and F. the
site of polyadenylation signals. Below are the roX1 transgenes generated for this
study (top 4) and selected excision mutations (bottom 4) that are illustrated with
respect to the transcribed region of roX1 (arrow). The hsp83 promoter is shown
as white box in front of each roX1 transgene. The survival of selected roX1
excision mutations is from (Deng et al, 2005)
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expression, the strong, constitutive hsp83 promoter was used. Transgenic flies
carrying each construct were generated. To avoid differences due to position
effect, all transgenes were integrated at the same site at 68A4 on the third
chromosome using the site-specific C31 integrase system (Groth et al., 2004).
To enable comparison between X-linked and autosomal insertions, the roX1R1-3
transgenes were also inserted at 2A3, 16C1, 18D3 and 19C4 on the X
chromosome by the same site-specific system (see Materials and Method). For a
control, a full length roX1 transgene, roX1FULL (bp -78–4150 of roX1), were also
generated and integrated at 68A4 and 16C1 by the C31 integrase system
(Figure 3-2).
Rescue of roX1 roX2 male lethality was used to measure the biological
activity of roX transgenes. Males carrying roX1R1-3 transgenes at the autosomal
site 68A4 were mated to roX1SMC17A roX2 virgin females. The only source of roX
RNA in the sons is from the roX1R1-3 transgene. The full length roX1 transgene,
roX1FULL, driven by hsp83 and integrated at the 68A4 site, supports over 90%
male survival (Table 3-4). As shown in Table 3-4, male viability is partially rescued
by each of the three deleted roX1 transgenes. roX1R2 supports highest male
survival, 54%, and roX1R1 supports lowest male survival, 33%. Rescue of
roX1mb710 roX2 chromosome is similar. Low rescue rate was expected, as each
roX1 transgene is deleted for most of the 5’ end of roX1. However, all roX1
transgenes are still capable of partially rescuing roX1 roX2 males. This confirms
previous studies suggesting that the 5’ end of roX1 contains multiple functional
elements with at least partial redundancy. All subsequent studies of transgene
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Table 3-4. Survival of roX1 roX2 males rescued by roX1R1, roX1R2 and roX1R3
transgenes integrated at 68A4 on third chromosome.
% male survival with autosomal transgene
X chromosome

No TG

[roX1R1]

roX1SMC17A roX2

7(978)

33(1722) 54(1744) 43(1725)

roX1mb710 roX2

5(1680)a

44(352)

[roX1R2]

51(416)

[roX1R3] [roX1FULL]

49(313)

96(643)
NA

roX1 roX2 females were mated to yw males homozygous for a roX1 transgene at
68A4. The male and female adults were counted. Female viability is set as 100%.
Male survival was expressed as the male to female ratio of offspring. The total
number of female adults counted in each case is in parentheses.
No TG, no transgene.
NA, not available.
a
Meller and Rattner, 2002.
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effect utilize the roX1SMC17A roX2 chromosome.

Restoration of MSL complex localization to the X chromosome by roX1R1-3
transgenes.
roX1 roX2 males display reduced MSL localization to the X chromosome
and ectopic MSL binding to the chromocenter and autosomal sites (Deng et al.,
2005; Meller and Rattner, 2002). To assess the role of 5’ roX1 sequences in MSL
localization, we prepared polytene chromosome spreads from male roX1SMC17A
roX2/Y; roX1R1-3/+ larvae and detected MSL1 localization by immunostaining.
roX1FULL, also integrated at the 68A4 site, is used as a control. roX1R1-3 partially
restore MSL recruitment to the roX1SMC17A roX2 X chromosome, but to different
extents (Figure 3-3). All three autosomal roX1 transgenes support high levels of
MSL complex binding to the X chromosome, but less than wild type or roX1SMC17A
roX2/Y; roX1FULL/+ males (Figure 3-3 A, C). Some ectopic MSL binding is still
observed, especially at the chromocenter of males carrying roX1R1-3. By contrast,
roX1FULL supports wild type level of MSL complex binding to the X chromosome
and no ectopic MSL binding except the roX1 integration site (compare panels A,
C, D, E and F of Figure 3-3). Among all roX1R1-3–rescued roX1SMC17A roX2 males,
the least ectopic MSL binding was observed in males carrying roX1R1. Males
carrying roX1R2 retained the most prominent ectopic binding of MSL at the
chromocenter. These results suggested that roX1 5’ end contains redundant
elements that act co-operatively to direct MSL localization to the X chromosme.
Comparing this with the ability of roX1R1-3 to rescue male survival reveals that the
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Figure 3-3. Autosomal roX1 transgenes partially restore MSL complex
localization to the X chromosome. MSL1 immunostaining of polytene
chromosomes from male larvae of (A) wild type, (B) roX1SMC17A roX2, (C)
roX1SMC17A roX2; [roX1Full], (D) roX1SMC17A roX2; [roX1R1], (E) roX1SMC17A roX2;
[roX1R2], (F) roX1SMC17A roX2; [roX1R3]. roX1 transgenes are integrated at 68A4
on third chromosome. The chromocenter is indicated by the triangle. The
integration site is indicated by the arrow. X marks the X chromosome. MSL1 is
detected with Texas Red (red). DNA is detected with DAPI (blue).
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ability of each transgene to promote X-localization does not agree precisely with
its ability to rescue males. roX1R2 support the highest male survival in spite of
strong ectopic binding of MSL at the chromocenter. However, although it directs
good MSL binding on X, roX1R1 support the lowest male survival.
MLE is an RNA/DNA helicase which may not associate with other MSL
proteins directly (Lee et al., 1997; Smith et al., 2000). It is possible that MLE
associates with the MSL complex by interaction with roX RNAs (Meller, 2003;
Richter et al., 1996). To determine whether roX1 transcripts from autosomal
roX1R1-3 transgenes are able to recruit MLE to the X chromosome, I performed
MLE immunostaining on polytene chromosome spreads from male roX1 SMC17A
roX2; roX1R1-3 larvae. For roX1R2 and roX1R3 rescued males, the binding pattern
of MLE is indistinguishable from that of MSL1 (Figure 3-4 C and D). This
suggests that RNA transcribed from the roX1R2 and roX1R3 transgenes enables
MLE to associate with the MSL proteins and localize to the X chromosome.
However, I could not see any restoration of MLE localization to the X
chromosome by roX1R1. Therefore, the roX1R1 RNA appears unable to interact
with MLE, or to mediate its integration into MSL complex. This could partially
explain the observations that although roX1R1 restores MSL1 localization to the X
as well as roX1R2 and roX1R3, the survival of males rescued by roX1R1 is lower.
This also suggests that although there is some redundancy among roX1R1-3,
these segments of roX1 may also contain distinct functions.

Accumulation of roX1R1-3 is determined by the 5’ sequence.

82

Figure 3-4. MLE immunostaining of polytene chromosomes from male
larvae. (A) wild type, (B) roX1SMC17A roX2; [roX1R1], (C) roX1SMC17A roX2; [roX1R2],
(D) roX1SMC17A roX2; [roX1R3]. roX1 transgenes are integrated at 68A4 on the
third chromosome. X marks the X chromosome. MLE is detected with Texas Red
(red). DNA is detected with DAPI (blue).
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Quantitative reverse transcriptional real-time PCR (Q-RT-PCR) was used
to determine the accumulation of transcripts from all transgenes. As expected,
roX1SMC17A roX2 males showed no detectable roX1 RNA accumulation, which
confirmed that the transgene was the sole source of roX1 transcript in the males
we tested (Figure 3-5). As roX1R1-3 transgenes are driven by the same promoter
and inserted at the same site, similar levels of transcription are anticipated.
However, the levels of roX1 transcript detected by Q-RT-PCR are different for
each transgene. All roX1R1-3 transgenes produce much lower level of roX1 RNA
than wild type (yw) males when integrated at the autosomal site 68A4. By
contrast, the full length transgene, roX1FULL, which is integrated at the same site,
accumulated about 3.5-fold more roX1 RNA than wild type males (Figure 3-5).
roX1R2 showed 7-fold higher roX1 RNA level than roX1R1, and transcript from
roX1R3 was virtually undetectable (Figure 3-5, black bars). We then compared
accumulation of roX1 transcripts produced from roX1R1-3 transgenes inserted at
68A4 (autosomal), 16C1 (X-linked) and 2A3 (X-linked). The trend of transcript
accumulation was essentially the same for roX1R1-3 (roX1R2 highest, roX1R3
lowest), regardless of the site of integration (Figure 3-5, black, gray and brown
bars). The high accumulation of stable transcript from roX1FULL confirms that
transcription driven by the hsp83 promoter is high. This suggests that the
dramatic difference in accumulation of transcripts from roX1R1-3 reflects the
stability of the RNA produced. roX1 RNA stability therefore depends on specific
sequences of roX1 transcript. Deletion of large amounts of roX1 sequence in
roX1R1-3 transgenes decreases the transcript stability dramatically.
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Figure 3-5. roX1 transcript levels in roX1 roX2 male larvae carrying roX1
transgenes. roX1 expression in the wild type control (+) was set to 1. The Y axis
is the level of roX1 accumulation in transgenic males divided by that in the wild
type control. Q-RT-PCR was normalized to the autosomal gene Dmn. Error bars
represent standard deviations of three independent biological replicates.
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Although the roX1 transcripts produced from roX1R3 were undetectable by
Q-RT-PCR, reverse-transcription followed by a regular PCR for 40 cycles
confirmed the presence of the anticipated gene product. This is consistent with a
previous study, which found that even undetectable levels of mutated roX1
transcript can support dosage compensation and surprisingly high levels of male
survival (Deng et al., 2005). PCR, followed by sequencing, revealed alternative
splicing within the 5' region of all roX1R1-3 transgenes (Figure 3-6). Since the
region amplified by Q-RT-PCR is located in the 3’ region of roX1 transgenes and
is present in all alternative splice forms, the accumulation of roX1 transcripts
detected by Q-RT-PCR reflects all of the roX1 transcripts present (primers for QRT-PCR are presented in Table 3-3).

roX1R1 directs MSL spreading in cis, while roX1R2 and roX1R3 do not.
The different levels of transcript accumulation enabled us to test the role of
roX abundance in spreading. The prevailing model of cotranscriptional assembly
of MSL proteins onto nascent roX transcripts predicts that lower roX transcript
accumulation promotes local spreading from sites of roX production, but when
roX transcripts are more abundant, local spreading is less likely to occur (Kelley
et al., 2008; Oh et al., 2003; Park et al., 2002). We therefore examined polytene
preparations for evidence of MSL localization at 68A4, the autosomal insertion
site of our roX1R1-3 transgenes. We observed that MSL binds to, but does not
spread from, the roX1R2 and roX1R3 insertions. In contrast, strong MSL
recruitment, and discontinuous spreading into flanking chromatin, was seen at
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Figure 3-6. Reverse transcription followed by PCR reveals multiple roX1
transcripts from the roX1R1-3 transgenes. The template was the same cDNA
used for Q-RT-PCR to detect the roX1 transcript level. The cDNAs were reverse
transcribed from three independent RNA samples extracted from 50 third instar
larvae of each genotype. Lane 1-3, roX1SMC17A roX2/Y; [roX1R1]/+. Lane 4-6,
roX1SMC17A roX2/Y; [roX1R2]/+. Lane 7-9, roX1SMC17A roX2/Y; [roX1R3]/+. The
marker is 100bp DNA ladder. The size of selected band is labeled on left of the
band. The highest band of each lane corresponds to the unspliced full length
transcript from roX1R1-3.
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the roX1R1 insertion site (Figure 3-3 arrow head, Figure 3-7). This is contrary to
our expectation that roX1R3, with lowest RNA accumulation, would spread most
readily from a transgene integration site. We conclude that transcript
accumulation is not the sole determinant of spreading in cis, and that the roX1R1
transgene either contains specific sequences that promote in cis spreading of the
MSL complex, or lacks sequences that block spreading in cis.

Transcript accumulation does not determine roX1R1-3 activity.
roX1 roX2 mutant males show a global decrease in X-linked gene
expression (Deng and Meller, 2006). To test whether roX1R1-3 transgenes are
able to rescue X-linked gene expression in roX1 roX2 males, individual genes
were measured by Q-RT-PCR in roX1SMC17A roX2 males carrying each transgene.
As expected, X-linked gene expression was partially restored by roX1R1-3
transgenes (Figure 3-8). Introduction of a copy of a roX1R1-3 transgene increases
expression of all X-linked, dosage compensated genes that were tested, as
compared to roX1SMC17A roX2 males. While the increase was variable and often
small (between 6 and 54%), in most cases the change was significant (p<0.01,
Figure 3-8).
Beadex mutations are dose-sensitive, gain of function alleles of Dlmo
(Shoresh et al., 1998). The X-linked Dlmo gene is dosage compensated by the
MSL complex, making Beadex mutations sensitive reporters for MSL complex
activity (Menon and Meller, 2009). Flies carrying Beadex mutations display
notching of wing margins, and the notching becomes more severe with increased
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Figure 3-7. The autosomal integration site of 68A4 enlarged to show MSL
binding and spreading from roX1R1, and binding but no spreading from
roX1FULL, roX1R2 and roX1R3. MSL1 immunostaining of polytene chromosomes
from male larvae of (A) roX1SMC17A roX2; [roX1Full], (B) roX1SMC17A roX2; [roX1R1],
(C) roX1SMC17A roX2; [roX1R2], (D) roX1SMC17A roX2; [roX1R3]. MSL1 is detected
with Texas Red (red). DNA is detected with DAPI (blue).
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Figure 3-8. Rescue of X-linked gene expression by roX1R1-3 transgenes.
Three X-linked dosage compensated genes were analyzed by Q-RT-PCR in
roX1SMC17A roX2 male larvae carrying roX1R1-3 transgene at 68A4. Expression in
roX1SMC17A roX2 males was set to 1. Values are the ratio of gene expression in
roX1SMC17A roX2 males carrying a roX1 transgene to that in roX1SMC17A roX2
males without a transgene. Q-RT-PCR was normalized to the autosomal gene
Dmn. Error bars represent standard deviations of three independent biological
replicate. P-values are determined by performing a two-sample unpaired t-test
between each genotype and control.
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expression of Dlmo. Beadex reporter analysis confirmed Q-RT-PCR findings
(Figure 3-9). There is no notching of wing margins in females carrying one
Beadex allele (Bxr49k) and one wild type allele. roX1mb710 roX2 Bxr49k males show
a low level of notching of wing margins (Menon and Meller, 2009), because of the
lower expression of Dlmo due to the failure of dosage compensation. roX1mb710
roX2∆ Bxr49k is a more severe allele that is lethal because of failure of dosage
compensation. No adult male is recovered from this allele. Survival is partially
rescued by introducing one copy of a roX1R1-3 transgene. These males show high
levels of notching of wing margins, suggesting that X chromosome dosage
compensation is improved. The level of notching is consistent with the
expression level of X-linked genes detected by Q-RT-PCR. roX1R2 showed least
notching, as well as least expression of Dlmo as detected by Q-RT-PCR, while
roX1R1 and roX1R3 were quite similar. However, there is no correlation between
the

level

of

transcript

from

the

roX1R1-3 transgenes and X-linked gene

expression levels. Transcript accumulation does not predict the ability of roX1R1-3
to rescue roX1 roX2 male viability, or to direct MSL spreading (Figure 3-5). Taken
together, these studies revealed that roX1 transcript levels alone do not
determine activity.

roX1R1 has a unique activity.
The ability of the extreme 5’ end of roX1 to direct MSL spreading in cis
from its autosomal transcription site (Figure 3-7) suggests that it might have a
role in marking the X chromosome. Both roX genes are located on the X
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Figure 3-9. Beadex responds to activity of roX1R1-3 transgenes. Wing from
(A) roX1mb710 roX2∆ Dp(1;1)Bxr49k/Y; [roX1R1]/+ male, (B) roX1mb710 roX2∆
Dp(1;1)Bxr49k/Y; [roX1R2]/+ male, (C) roX1mb710 roX2∆ Dp(1;1)Bxr49k /Y; [roX1R3]/+
male. (D) The amount of wing margin lost is represented as the percentage of L3
vein length. Twenty wings from each group were measured.
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chromosome, and it has been suggested that this helps target dosage
compensation to the X chromosome. However, full length autosomal roX
transgenes can fully rescue survival of roX1 roX2 males, calling into question the
role of spreading in cis. To examine this, roX1R1-3 transgenes were integrated at
four more sites, 2A3, 16C1, 18D3 and 19C4, on the X chromosome. The 18D3
landing site, in an intron of the Tao-1 gene, is viable but integration of any of the
roX1 transgenes into this site is lethal. Integrations at the other three sites are
viable. roX1R1-3 transgenes integrated at 2A3, 16C1, and 19C4 were recombined
onto the roX1SMC17A roX2 chromosome. roX1SMC17A roX2 roX1R1-3/Binsincy
females were mated to yw males to produce roX1SMC17A roX2 roX1R1-3 sons. The
only source of roX RNA in the sons is the X-linked roX1R1-3 transgene. roX1R2
and roX1R3 transgenes integrated at 19C4 rescued roX1SMC17A roX2 males
somewhat less than the autosomal integration, while roX1R1 from this site
showed no rescue of roX1SMC17A roX2 males (Table 3-5). 19C4 is a
heterochromatic region. The expression of any transgenes inserted in this region
could be suppressed by the heterochromatic environment. We expect that the
lower rescue is due to low expression of roX1R1-3 transgenes. This is supported
by the fact that the expression of the white marker gene at this site was
variegating and hard to detect. When integrated at 16C1, roX1R2 and roX1R3
displayed similar rescue to that observed for integrations at the autosomal 68A4
site. Unexpectedly, roX1R1 showed no rescue of roX1SMC17A roX2 males from
16C1 (Table 3-4 and 3-5). This was puzzling, as the accumulation of roX1R1 is
identical when it is integrated at 16C1 and 68A4 (Figure 3-5). When integrated at
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Table 3-5. Survival of roX1 roX2 males that are rescued by roX1R1, roX1R2
and roX1R3 transgenes inserted on the X chromosme.
Transgene

% male survival with X-liked transgenes

Integration Site

[roX1R1]

[roX1R2]

[roX1R3]

[roX1FULL]

2A3

16(1010)

70(1517)

60(1205)

NA

16C1

9(5150)

52(1865)

33(2546)

99(570)

19C4

8(679)

29(316)

31(304)

NA

To rescue roX1 roX2 males by X-linked roX1 transgene, roX1R1-3 transgenes
inserted at the indicated sites were recombined to roX1SMC17A Df(1)52 X
chromosome. roX1 Df(1)52 [roX1R1-3]/Binsincy females were mated to yw males
homozygous for [w+4∆4.3]. The non-Binsincy male and female adults were
counted. The female viability is set at 100%. Male viability was expressed as the
ratio of males to females recovered. The total number of female adults counted in
each case is in parentheses.
NA: not available.
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another X-linked site, 2A3, roX1R2 and roX1R3 displayed higher male rescue than
all other sites. roX1R1 also showed higher male rescue from this site than from
16C1 and 19C4 (Table 3-5). This is consistent with a higher transcript
accumulation of roX1R1 and roX1R2 transcribed from this site than from 16C1 and
68A4 (transcript from roX1R3 is still undetectable, Figure 3-5 brown bars).
However, the rescue of roX1SMC17A roX2 males by roX1R1 integrated at 2A3 was
only about half of that by roX1R1 integrated on an autosome. Because the roX1R1
transgene has a unique ability to direct spreading of the MSL complex in cis, we
hypothesized that the failure of rescue was due to abnormal local accumulation
of MSL complex adjacent to the site of roX1R1 integration. We reasoned that this
prevents spreading to dosage compensate the rest of the X chromosome.
To resolve this question, I asked whether genetic manipulations that
reduce MSL spreading increase male survival when rox1R1 is X-linked. Reduced
levels of the MSL proteins MSL1 or MSL2 inhibit MSL spreading in cis from a roX
transcription site (Oh et al., 2003). To reduce the dose of MSL1, I introduced a
loss of function copy of msl1 (msl1L60) by mating roX1SMC17A roX2 roX1R1 16C1
females to males carrying this mutation. Reduction of MSL1 did not rescue males
with X-linked roX1R1 at 16C1 (Figure 3-10). Indeed it dramatically decreased
roX1SMC17A roX2 roX1R1 male survival. In contrast, reduction in the level of MSL3
and MLE had no discernable effect on male survival (Figure 3-10). Similar results
were obtained with roX1R2 and roX1R3 transgenes integrated at the same site
(Figure 3-10). This is consistent with previous studies demonstrating that the
level of MSL1, but not MSL3 or MLE, is limiting for dosage compensation.
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Figure 3-10. Survival of roX1SMC17A roX2 roX1R1-3 males after manipulation of
MSL protein levels. roX1R1-3 transgenes were located at 16C1 on the X
chromosome. The survival of males is based on emergence of females of the
same genotype, with the exception that females carry one wild type X
chromosome and one roX1 roX2 roX1R1-3 chromosome (female viability is set to
100%, see Materials and Methods for a description of crosses). The X
chromosome genotype of each male is depicted on the X axis. The labels on the
top right is the genotype of autosome in each case. “+” means wild type. The msl
mutants used are msl1L60, msl32 and mle1. [M1][M2] chromosome carries hsp83driven transgenes that overexpress msl1 and msl2. Full genotype is roX1SMC17A
Df(1)52 roX1R1-3; [w+4∆4.3].
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Simultaneous overexpression of MSL1 and MSL2 from transgenes increased the
survival of roX1SMC17A roX2 roX1R1 males by almost two fold, but roX1SMC17A roX2
roX1R2 and roX1SMC17A roX2 roX1R3 males did not benefit from MSL
overexpression (Figure 3-10). Overexpression of MSL1 and MSL2 promotes
speading in cis from roX genes and transgenes (Oh et al., 2003; Park et al.,
2002). My results indicate that uneven localization of the MSL complex along the
X chromosome is not the reason why roX1R1 can not rescue from 16C1 on the X
chromosome. My findings instead suggest that the failure of roX1R1 to support
dosage compensation when transcribed from the X chromosome is the reason
for low male survival.
To investigate whether the failure of roX1R1 to support dosage
compensation is a result of failure of proper localization of the MSL complex on
the X chromosome, we prepared polytene chromosome spreads from male
roX1SMC17A roX2 roX1R1-3 larvae and detected MSL1 localization by immunostaining. As shown in figure 3-11, when integrated at 16C1, roX1R1 failed to
restore MSL complex localization to the X chromosome, while roX1R2 and roX1R3
partially restored MSL complex localization to the X chromosome. Therefore,
roX1R1 behaves differently in directing the localization of the MSL complex. It is
able to direct MSL localization in trans from an autosomal site, but not from this
X-linked site.
I then asked whether roX1R1 is toxic in cis to the X chromosome. I
reasoned that there might be a very dose-sensitive gene close to the 16C1
integration site. The local accumulation of MSL complex in roX1SMC17A roX2
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Figure 3-11. X-linked roX1 transgenes partially restore MSL complex
localization to the X chromosome. MSL1 immunostaining of polytene
chromosomes from male larvae of (A) roX1SMC17A roX2, (B) roX1SMC17A roX2
[roX1R1], (C) roX1SMC17A roX2 [roX1R2], (D) roX1SMC17A roX2 [roX1R3]. roX1
transgenes are integrated at 16C1 on X chromosome. X marks the X
chromosome. MSL1 is detected with Texas Red (red). DNA is detected with DAPI
(blue).
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roX1R1 males might disrupt expression of this gene, leading to lethality. If this is
the case, the roX1R1 transgene is likely to be toxic in a fly with wild type roX1
supplied as well. A full length roX1 transgene driven by hsp83 and integrated at
68A4, roX1FULL, was introduced to test this idea. The autosomal roX1FULL almost
fully rescues roX1SMC17A roX2 roX1R1 males (Table 3-6). Transcript produced from
roX1Full is stable and accumulates to high levels compared to roX1R1 (Figure 3-5).
This transcript could overcome the effect of roX1R1 transcript by competing for
binding to MSL proteins. We next tested whether the much less stable roX1
transcripts produced from roX1R2 and roX1R3 could rescue roX1SMC17A roX2
roX1R1 males. Introducing a single copy of roX1R2 or roX1R3 integrated at 68A4
rescued roX1SMC17A roX2 roX1R1 males to a similar extent as achieved by roX1R2
and roX1R3 when there is no roX1R1 transgene on the X chromosome (Table 3-6).
Remarkably, roX1R1 at 68A4 also rescues roX1SMC17A roX2 roX1R1 males. The
extent of rescue is identical to that when there is no roX1R1 transgene at 16C1.
Taken together, these results indicate that roX1R1 integrated at 16C1 is not toxic.
Rather, it appears that the RNA produced from this site is uniquely unable to
participate in some vital aspect of dosage compensation. When performing the
same rescue of roX1SMC17A roX2 roX1R2 and roX1SMC17A roX2 roX1R3 by
autosomal roX1 transgenes, the effect of two transgenes together is not additive
(Table 3-6). This suggests that different roX1 transcripts do not work together to
complement deficiencies in the function of each transcript.

99

Table 3-6. Rescue of roX1 roX2 roX1R1-3 males by autosomal roX1
transgenes.
% male survival with autosomal transgenes
X chromosome

No TG

[roX1R1]

[roX1R2]

[roX1R3] [roX1FULL]

roX1SMC17A roX2

7(978)

33(1722) 54(1744) 43(1725)

96(643)

roX1SMC17A roX2 roX1R1

9(5150)

32(274)

40(252)

52(249)

83(563)

roX1SMC17A roX2 roX1R2

52(1865)

47(175)

59(170)

67(166)

97(274)

roX1SMC17A roX2 roX1R3

33(2546)

49(185)

61(186)

60(174)

115(234)

roX1SMC17A roX2 roX1R1-3 X chromosomes carry the roX1 transgene at 16C1. To
rescue roX1 roX2 roX1R1-3 males by autosomal roX1 transgenes, roX1 roX2
roX1R1-3/Binsicy females were mated to yw males homozygous for the indicated
roX1 transgene at 68A4. Adults, all of which carry one copy of the autosomal
roX1 transgene, were counted. The female viability is set to 100%. Male viability
was expressed as the percentage of males to females emerging from each cross.
The total number of female adults counted in each case is in parentheses.
No TG: no autosomal transgene.
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DISCUSSION

Both roX and Xist genes direct binding of chromatin complexes that coat
the X chromosome to achieve dosage compensation. Both genes are able to
recruit chromatin complexes in cis to the site of RNA production, but for neither
molecule do we understand how this occurs at the molecular level. Our studies
now reveal that a portion of roX1 that is only present in a minor fraction of
naturally occurring transcripts contributes to the MSL complex spreading in cis.
When roX1 transgenes are transcribed from an autosomal site, the MSL complex
spreads discontinuously from the roX1R1 transcription site to flanking regions. In
contrast, it binds to but does not spread from the roX1R2 and roX1R3 transcription
site (Figure 3-7). MSL spreading from the roX1R1 transcription site shows a
discontinuous pattern, as does spreading from a full length roX1 autosomal
transgene (Kelley et al., 1999; Meller et al., 2000). This observation argues that
all the spreading occurs by a similar mechanism. However, the region of
spreading from a wild type roX1 transgene can cover an extensive region, while
spreading from roX1R1 is only into two adjoining, strongly-labeled bands.
It has been proposed that the MSL complex assembles co-transcriptionally
on nascent roX transcripts, and spreads from these sites to adjacent, transcribed
genes. The concept of spreading comes from the observed properties of
heterochromatin. Heterochromatin can spread in cis from an initiation site along a
chromosome for a long distance (Schuettengruber et al., 2007; Talbert and
Henikoff, 2006; Wutz, 2003). This is believed to occur by linear propagation along
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chromatin. Propagation involves silencing histone modifications (i.e., H3K9me)
that serve to recruit proteins that make silencing histone modifications (i.e., Clr4),
leading to spreading from sites of initiation. The mechanism of MSL complex
spreading from a roX nucleation site to flanking regions is still unknown. It was
found that a high ratio of MSL proteins to roX transcripts promoted local MSL
spreading from sites of roX transcription (Kelley et al., 2008; Oh et al., 2003; Park
et al., 2002). A model that local MSL spreading is controlled by the efficiency of
MSL complex assembly onto nascent roX transcripts before their release was
proposed. According to this model, there is an inverse relationship between the
speed of MSL complex assembly and the ability of the MSL complex to spread
from the site of roX transcription. Slower transcription or more MSL proteins
produces more active MSL complex in the vicinity of the roX genes. This
promotes binding to nearby chromatin. Decreased abundance of roX transcript
also promotes assembly of intact MSL complexes prior to release of the roX
transcript from the chromatin template. However, the roX1R1 transgene has
intermediate transcript accumulation compared to roX1R2 and roX1R3 (Figure 3-5).
Therefore, the transcript abundance of roX1R1, roX1R2 and roX1R3 does not
predict their ability to direct MSL spreading in cis. We propose that the ability to
direct spreading in cis is intrinsic to RNA or DNA sequences that are contained
within the roX1R1 transgene, but missing from roX1R2 and roX1R3.
All roX1R1-3 transgenes are driven by the same promoter, inserted at the
same site, and thus expected to be transcribed at the same level. However, each
of the roX1R1-3 transgenes displays a different level of transcript accumulation.
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The hsp83 promoter drives strong transcription of roX1 transgenes. However, the
accumulation of the transcripts from roX1R1-3 is much lower than wild type.
Transcript from roX1FULL transgene, driven by the same promoter and inserted at
the same site, showed much higher RNA accumulation than wild type. The high
accumulation of the transcript from roX1FULL confirms that transcription driven by
the hsp83 promoter is strong. This suggests that the dramatic difference in
transcript accumulation reflects the stability of the RNA produced. roX1R3 is quite
unstable compared to roX1R2 and roX1R1, and roX1R2 is more stable than roX1R1,
but accumulation remains ten times less than roX1FULL when expressed from the
same site. roX1R1-3 transgenes have deletion of large roX1 sequences, which
decreases the transcript stability dramatically. This indicates that roX1 RNA
stability needs cooperation of several roX1 sequences, consistent with the idea
that roX1 contacts several proteins following integration into the MSL complex.
However, we can not exclude the possibility that the transcription elongation rate
of each roX1 transgene is different, and this contributes to different transcript
accumulation from each transgene. An in vivo transcription run-on assay could
be used to investigate the transcription elongation rate from each roX1 transgene.
Binding of the MSL complex to the roX1 transgene could interfere with the
transcription elongation. However, the accumulation of the MSL complex at the
integration site of roX1 transgenes does not correlate with the accumulation of
the transcript from corresponding roX1 transgenes. Moreover, the roXFULL
transgene contains all 5' sequences, transcription of roXFULL would presumably
be limited by any 5' sequences that slow elongation. Since accumulation of
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roXFULL is highest, elongation alone does not explain the transcript accumulation
levels from these transgenes. My data is most consistent with the stability of
each transcript being primarily responsible for RNA accumulation.
Males carrying a roX1 allele missing a large part of the 5’ sequence
display ectopic MSL binding to heterochromatic region and some autosomal sites
and reduced binding on the X chromosome (Deng et al., 2005). All roX1R1-3
transgenes with different fragments of the 5’ end partially rescue male survival
and MSL localization to the X chromosome (Table 3-4, Figure 3-3), supporting
the idea that this region contains multiple elements necessary for targeting of the
MSL complex to the X chromosome. The incomplete rescue of male survival and
MSL localization by each roX1R1-3 transgene indicates that several of these
elements act co-operatively for MSL localization. As the roX1 5’ end lacks
obvious conserved sequences, this redundancy may operate at the level of RNA
structure.
An internal deletion mutant of roX1, roX1ex40A, that retains only the roX1R1
and roX1R2 5’ fragments and the 3’ end, supports full male survival, leading to the
conclusion that these are the only regions of roX1 necessary for function (Deng
et al., 2005). However, although the 5’ sequence of roX1R3 is not present in the
roX1ex40A mutation, we clearly detect the function of this region by MSL
localization driven by the roX1R3 transgene. This was expected since the most
active roX1 transcription start site is situated at bp 628, slightly upstream from
the beginning of the 5' fragment cloned into roX1R3.
Although roX1ex40A restores full male viability, co-expression of roX1R1 and
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roX1R2 transgenes, which together contain all 5' sequences present in roX1ex40A,
does not fully rescue male survival. This supports previous studies showing that
neither 3’ 1 kb nor 5’ 2.5kb roX1 fragments rescues male survival or MSL
localization, which suggested that roX RNA fulfills its function through
simultaneous interaction with different molecules (Meller and Rattner, 2002;
Stuckenholz et al., 2003). We do not know if the MSL complex contains more
than one roX RNA. However, my finding that roX1R1 and roX1R2 can not
complement each other suggests that the MSL complex may contain a single roX
RNA.
The roX1R2 and roX1R3 transgenes enable MSL1 and MLE to bind to the X
chromosome, suggesting that roX1R2 and roX1R3 transcripts simultaneous
interact with multiple MSL proteins. However, roX1R1 partially restores MSL1 but
not MLE localization to X chromosome. The helicase activity of MLE, as well as
an RB1 RNA-binding domain in this protein, is reported to be important for
normal spreading of the MSL complex on the X chromosome and for movement
of the roX RNAs from their sites of synthesis (Gu et al., 2000; Meller et al., 2000;
Morra et al., 2008; Morra et al., 2011). It is puzzling that roX1R1 can promote MSL
spreading from its production site, but does not recruit MLE. It is possible that the
relatively short roX1R1 transcript does not require the helicase activity of MLE for
assembly and spreading (Figure 3-12 A). Other possible models for roX1R1
directed spreading without binding to MLE can also be postulated. It is possible
that the MSL complex requires dissociation of MLE to spread from the primary
binding site to different sites, and that the MLE helicase activity is required for the
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Figure 3-12. Models of roX1R1-directed spreading of MSL complex from its
transcription site. (A) Full length roX1 requires the MLE helicase for movement
from a site of transcription. Relatively short roX1R1 transcript does not need MLE.
(B) MLE must dissociate from the MSL complex to allow spreading to a different
site. Dissociation of MLE requires MLE helicase activity. Because roX1R1 never
recruits MLE, it spreads in cis more readily. (C) MLE is required for repositioning
of chromatin bound MSL complex. When MLE is incorporated into the MSL
complex, the complex can move to other sites. However, without MLE, it is
sequestered in the place of first association. This creates a high concentration of
MSL complex locally, enhancing the appearance of spreading to regions
surrounding the site of transcription.
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dissociation. Since roX1R1 transcript never recruits MLE to the MSL complex, it
can spread more readily (Figure 3-12 B). Another possible explanation is that
MLE is necessary for mobility of MSL complex that has bound to chromatin. The
MSL complex is thought to first bind to chromatin entry sites, or sites close to the
roX genes, and then spread to other sites on the X chromosome. In this model,
chromatin bound MSL complex can move to other sites only when MLE is
present and active. Without MLE, the MSL complex is sequestered at the place
of first association (Figure 3-12 C). This would create a high concentration of
MSL complex surrounding the site of roX transcription (Figure 3-12 C). Although
counterintuitive, this model suggests that what appears to be avid local spreading
from a roX1R1 transgene is in fact the consequence of the inability of a partial
complex lacking MLE to travel from its initial binding site.

The resolution of

polytene chromosome immunostaining is relatively low. Although MSL1
localization on an X chromosome rescued by autosomally produced roX1R1 is
similar to that observed with roX1R2 and roX1R3, we can not determine if the
spreading of MSL complex on the X chromosome is normal. The effect of MLE on
spreading of the MSL complex over short distances may only be detectable by
high-resolution techniques such as ChIP-chip or ChIP-seq. For example, ChIPseq was used to establish that the MSL3 chromo-domain is necessary for the
MSL complex to spread to actively transcribed genes, in spite of the fact that
immunostaining of polytene chromosome did not detect reduced MSL localization
in an MSL3 chromo-domain mutant (Sural et al., 2008).
roX genes are normally located on and transcribed from the X
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chromosome, and assemble with the MSL proteins to coat the X chromosome
(Amrein and Axel, 1997; Meller et al., 1997). It has been suggested that Xlinkage of the roX genes contributes to targeting MSL complex to the correct
chromosome. Autosomal roX1 transgenes enable the MSL complex to bind to the
X chromosome in trans and rescue roX1 roX2 males, even though roX RNAs are
usually transcribed from X. If roX1 is wild type, the insertion site is immaterial.
However, studies on the partial loss of function roX1ex7B mutant suggest that
partially functional roX1 transgenes may be more active if they are inserted on
the X chromosome. The roX1ex7B mutation has an internal deletion of 2.3 kb,
leaving the same 5’ sequence present in roX1R1 (Figure 3-2). The roX1ex7B
mutation on the X supports ~43% male survival, but an autosomal hsp83-driven
roX1ex7B transgene that begins at bp 47, and is thus slightly 5’ truncated,
supports only ~14% male survival. However, male rescue by autosomal roX1R1 is
much higher (33%-44%). Although position effects become a confounding factor
when insertions at different sites are compared, X-linked integrations of roX1R1-3
transgenes do not consistently show higher activity. The lower male survival
resulting from the autosomal roX1ex7B transgene thus appears to not be due to its
autosomal location. The roX1ex7B transgene starts 120 bp downstream of the
roX1R1 start site. The sequence lacking in the roX1ex7B transgene is thus the likely
cause of its decreased male rescue.
When roX1R1-3 are expressed from a single integration site, the rescue of
roX1 roX2 males by roX1R2 is highest and by roX1R1 is lowest. The trend is the
same for all integration sites. Unexpectedly, roX1R1 showed much lower or no
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rescue of roX1 roX2 males transcribed from the X chromosome (Table 3-5). This
is not due to differences in expression, and is not because roX1R1 is toxic to
nearby genes. Lack of effective recruitment of the MSL complex, and low support
of dosage compensation is more likely responsible for low male rescue by Xlinked roX1R1. A model based on a requirement for MLE to reposition chromatinbound MSL complex is proposed (Figure 3-13). In this model, we hypothesize
that the MSL complex containing roX1R1 but no MLE can bind chromatin.
However, the MSL complex needs the MLE helicase for release from chromatin
and repositioning at other sites (i.e., within body of genes). Without MLE, the
roX1R1-containing MSL complex is unable to move from initial binding site,
resulting in excessive accumulation at the site of transcription. When roX1R1 is
transcribed from an autosomal site, because the surrounding autosome is less
permissive for MSL attachment, only very closely linked sites accumulate for the
MSL complex. The nucleoplasm is filled with MSL complexes that ultimately find
sites on the X chromosome. However, when roX1R1 is transcribed from the X
chromosome, the MSL complex immediately binds nearby X chromatin. However,
subsequent redistribution to more transcribed genes on the X chromosome can
not occur. This raises the question of why the similar roX1ex7B RNA, transcribed
from the X chromosome under the control of the weaker roX1 promoter,
produces reasonably good (40-50%) male survival. One possibility is that the
abundant supply of roX1R1 enables most of the MSL proteins to bind chromatin,
depleting the pool of free MSL proteins in the nucleoplasm. A newly transcribed
gene will consequently find it extraordinarily difficult to recruit MSL complex. The
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Figure 3-13. Mobility of the MSL complex depends on roX1 and MLE. (A)
After assembly of the MSL complex, chromatin entry sites are bound. The
complex then spreads to transcribed genes. (B) MSL complex containing roX1R1
can bind X chromatin, but can not be repositioned as it lacks MLE activity.
Spreading to nearby transcribed genes is inhibited. (C) When roX1R1 is
transcribed from an autosomal site, closely linked sites accumulate the MSL
complex. However, autosomal binding is inefficient and the nucleoplasm is filled
with MSL complexes that ultimately finds a wide range of binding sites on the X
chromosome. (D) When roX1R1 is transcribed from the X chromosome, the MSL
complex is titrated out of the nucleoplasm by binding to nearby chromatin entry
sites and transcribed genes. Bound complex is unable to redistribute to
transcribed genes on the X chromosome.
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fact that forced expression of MSL1 partially rescues roX1 roX2 males carrying
the roX1R1 transgene is consistent with this interpretation. Future studies testing
these models may lead to a deeper understanding of how roX RNAs contribute to
X identification, and the molecular mechanisms that underlie spreading in cis
from a site of roX transcription.
In a summary, regions of roX1 RNA with distinct functions have been
identified throughout the 5’ end of roX1 by these studies (Figure 3-14). Multiple
redundant elements that act co-operatively to contribute to X chromosome
targeting of the MSL complex are distributed throughout the 5’ end of the roX1
transcript. The extreme 5' portion of roX1 that is present in roX1R1 displays a
unique activity, promoting MSL complex spreading from the site of transcription.
However, only the sequences present in roX1R2 and roX1R3 are able to recruit
MLE.
Naturally occurring roX1 transcripts reveal minor and major transcription
start sites that are developmentally regulated. The 5’ ends of roX1R1-3 transgenes
roughly correlate with the transcription start sites of the three dominant roX1
isoforms (Figure 3-2). The roX1R1 transgene contains a region only expressed in
a minor population of roX1 transcripts. This suggests that utilization of different
transcription start sites is carefully regulated, and may contribute to normal
distribution of the MSL complex. The activities I have detected are expected to be
regulated by choice of transcription start site, alternative splicing and/or transcript
stability.
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Figure 3-14. Schematic illustration of functional roX1 domains. The top line
indicates the roX1 genomic region, numbering from (Amrein and Axel, 1997).
The transcribed roX1 region is shown as an arrow. The arrows above are: A. The
start site of a minor class of roX1 ESTs (expressed sequence tags) B. A more
frequently used roX1 transcription start site. C. The transcription start site of the
majority roX1 transcripts. Below are the roX1 functional domains with respect to
the transcribed region of roX1. Data is compiled from the following references. 1)
Stuckenholz et al., 2003. 2) Park et al., 2008. 3) Kelley et al., 2008. 4) Deng et al.,
2005.
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CHAPTER 4

FUTURE DIRECTIONS

The results described in this study provide insight into chromosome-wide
regulation by a large non-coding RNA. However, roX1 function has not yet been
completely elucidated. Addressing the following questions will enable a better
understanding of how roX1 carries out its function, and how this process is
regulated.

What mechanism restricts roX regulation of heterochromatin to males?
roX RNAs participate in two distinct biological processes in Drosophila
melanogaster males: dosage compensation and normal heterochromatin function.
Dosage compensation increases expression from the male X chromosome to
compensate for X chromosome monosomy. Dosage compensation is limited in
males by repression of MSL2 in females (Kelley et al., 1997). However,
heterochromatin is present in both sexes. All known components of the roXdependent heterochromatic modulation system (roX RNA, MLE, MSL1, MSL3
and MOF) are present in early female embryos (Deng et al., 2009; Meller, 2003;
Rastelli et al., 1995). We speculate that these molecules associate to form a
complex that serves a transient role in formation of heterochromatin in male
embryos. What prevents this from occuring in females is unclear. SXL binding
sites in roX1 provide a plausible point for regulation of this system by the female-
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limited SXL protein (Meller et al., 1997). However, expression of roX1 lacking
these sites does not influence the expression of heterochromatic genes in
females. Other possibilities exist. There could be additional factors that
participate in roX-dependent heterochromatin modulation that are only present in
males, or active in males. It is also possible that additional factors block this
system in females. To investigate this possibility, roX1 pull-down could be
performed in male and female embryos, followed by a LC-MS/MS (Liquid
Chromatography coupled with Tandem Mass Spectrometry) to identify roXinteracting factors. Different proteins associated with roX1 in males and females
could be the factors that limit this system to males. However, this interaction
could be transient and weak, making it difficult to identify through a general roX1
pull-down. Specific developmental stages and pull-down conditions are critical for
this experiment.

What roX1 regions are required for the regulation of heterochromatin?
It is possible that roX RNA interacts with different proteins when
modulating heterochromatin and the X chromosome. These interactions could
occur through distinct functional domains of roX1. It is of considerable interest to
identify roX1 sequences that participate in each of the known functions of this
molecule. Multiple regions of roX1, with unique functions, are important for
dosage compensation. One candidate roX1 region suggested by our preliminary
data to be required for heterochromatin regulation was found to be dispensable
for this process. However, a systematic study of roX1 mutations or transgenes
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deleted for different regions could be used to identify regions necessary for
heterochromatin. The roX1 transgenes I created to test in dosage compensation
can now be used for this purpose (Chapter 3). These roX1 transgenes could be
analyzed to determine their ability to restore the expression of heterochromatic
genes in roX1 roX2 males.

Is there a direct interaction between 5’ roX1 sequences and MSL proteins?
I have suggested that the function of intact roX1 requires simultaneous
interaction with different molecules. It is easy to imagine that roX1 contacts
multiply MSL proteins. Identification of sequences binding to each protein will
help to elucidate how roX1 exerts its function. My results revealed multiple
redundant elements throughout the 5’ region of the roX1 transcript that cooperate
in X chromosome targeting. Because roX1R1-3 each contains a subset of these
elements, they have partial function in directing MSL binding and supporting male
survival. We can perform an in vitro transcription of the 5’ portion of these
transgenes and test if there is any physical interaction with any MSL proteins
using gel mobility shift assay. If successful, we can further narrow down the
functional elements by producing smaller RNA within the interacting region and
test for interaction.

What prevents roX1R1 from rescuing roX1 roX2 males from X-linked
insertion sites?
roX RNAs are normally located on and transcribed from the X
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chromosome, and assemble with the MSL proteins to coat the X chromosome
(Amrein and Axel, 1997; Meller et al., 1997). It has been suggested that Xlinkage of the roX genes contributes to targeting of the MSL complex to the X
chromosome (Kelley et al., 1999). We expected that a roX1 transgene able to
direct MSL complex localization to flanking chromatin would have higher rescue
activity when inserted on the X chromosome than when inserted on an autosome.
In contrast to our expectation, my roX1 transgenes did not display higher activity
when expressed from the X chromosome. Unexpectedly, one transgene, roX1R1,
showed no rescue of roX1 roX2 males when transcribed from 16C1 or 19C4 on
the X chromosome. While 19C4 is in proximal heterochromatin, perhaps lowering
the effect of this site, roX1R1 is expressed at the same level when inserted at
16C1 and at 68A4 on the 3rd chromosome. My studies suggest that this insertion
of roX1R1 fails to rescue males due to a deficiency of dosage compensation,
rather than toxicity due to an elevated recruitment of MSL proteins to a particular
site on the X chromosome. When integrated at another X-linked site, 2A3, roX1R2
and roX1R3 showed higher male rescue than the autosomal site, but roX1R1 still
displayed very low rescue of roX1 roX2 males. Future studies to understand why
the transcription of roX1R1 from an autosomal site will partially rescue roX1 roX2
males, but transcription from the X-linked sites fails to rescue these males may
provide insight into the interplay between the roX1 promoter, 5’ regions of the
roX1 transcript and spreading in cis.

Do different roX1 isoforms perform different functions?

116

roX1 displays minor and major transcription start sites that are
developmentally regulated. I generated a full length roX1 transgene that fully
rescues X-lined gene expression, but only partially restores expression from
fourth-linked heterochromatic genes. This incomplete rescue could be due to
other aspects of the intrinsic roX1 gene, such as correct balance of transcripts
from alternative start sites or developmental regulation of transcription start sites.
Different roX1 activities may be regulated by choice of transcription start site,
alternative splicing and/or transcript stability. A previous study suggested that
variable alternative roX2 splice forms are important for modulating the activity of
the MSL complex (Park et al., 2005). My study and others all suggest that
alternative splicing occurs in the 5’ roX1 region. A more complete analysis of
alternative splicing and transcription start site utilization might provide clues to
the different roles of roX1 transcripts. My studies indicate that the roX1R1
transgene has the ability to direct spreading in cis from the site of roX1R1
transcription. The fact that the 5’ portion of roX1 included in roX1R1 is present in
very few endogenous roX1 transcripts suggests that regulation of transcription
start site may regulate this aspect of roX1 function.
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APPENDIX A

MINIMUM INFORMATION ABOUT MICROARRAY ANALYSIS OF ROX IN
FEMALES

MIAME

This document contains minimum information for the microarray experiment of
roX1 roX2 mutant females in chapter 2.

1. Experimental design:
a) The goal of the experiment
Determine if roX RNAs regulate expression in Drosophila females.

b) Author (submitter), laboratory, contact information, links (URL), citation
Y. Kong
V. Meller
Department of Biological Sciences
5047 Gullen Mall
Wayne State University, Detroit, MI 48202

c) Type of the experiment
effect of roX1 roX2 mutant chromosome on gene expression in females
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d) Experimental factors.
mutation of both roX1 and roX2 genes

e) Single or multiple hybridizations
Single hybridizations:
* Serial (yes/no)
no
* Grouping (yes/no)
yes

Samples:
Group 1: roX1SMC17ADf(1)52; [w+4∆4.3] (roX1 roX2 mutant female larvae)
Group 2:

roX1SMC17ADf(1)52; [w+4∆4.3]; [hsp83-roX1+] (control female

larvae)

Arrays: 1, 2, 3, 4, 5, 6
Hybridizations:
Group 1,
H1: Array 1, VM_roX-1 (mutant)
H2: Array 2, VM_roX-2 (mutant)
H3: Array 3, VM_roX-3 (mutant)
H1, H2 and H3 are biological triplicates.
Group 2,
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H4: Array 4, VM_roX+4 (control)
H5: Array 5, VM_roX+5 (control)
H6: Array 6, VM_roX+6 (control)
H4, H5 and H6 are biological triplicates.

f) Quality related indicators quality control steps taken:
* Biological triplicates for each genotype

* Other
RNA quality is analyzed on the Agilent 2100 Bioanalyzer.

Affymetrix positive and negative controls, including:
Hybridization controls: bioB, bioC, bioD from E. coli and cre from P1
bacteriophage
Poly-A controls: dap, lys, phe, thr, trp from B. subtilis
Drosophila

maintenance

genes:

Actin

(Actin

42A),

GAPDH

(Glyceraldehyde 3 phosphate dehydrogenase 2), Eif-4a (Eukaryotic
initiation factor 4a)

Affymetrix PM-MM (Perfect match- Mismatch) comparison for unspecific
binding.

g) A free text description of the experiment set or a link to a publication
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The global effect of roX mutations on gene expression in females was
measured by microarray analysis. Three independent RNA preparations
for each genotype served as templates for probe synthesis. These probes
were hybridized to Affymetrix Drosophila Genome 2.0 chips. Affymetrix
Gene expression data was background corrected, normalized and
summarized into a one expression value per sample and probeset using
the RMA (robust multi-array average) algorithm. Changes in gene
expression were determined by comparing the mean signal intensities of
genes on arrays hybridized with roX1 roX2 (mutant) probes to those
hybridized with roX1 roX2; [hsp83-roX1+] (control) probes.

2. Array design: each array used and each element (spot) on the array
2.1 Array copy: each array used and each element (spot) on the array.
* Unique id as used in part 1
1, 2, 3, 4, 5, 6

* Array design name
Affymetrix Drosophila Genome 2.0 chips

2.2 Array related information
Affymetrix eukaryotic gene expression analysis arrays
See http://www.affymetrix.com/products/arrays/specific/fly_2.affx
All transcript alignments, Gene Names and Probe set IDs were extracted
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from the Affymetrix Drosophila 2 annotation file.

3. Samples: samples used, extract preparation and labeling
a) Bio-source properties
* Samples
Three independent RNA preparations from roX1 roX2 mutant female
larvae and three from control female larvae (roX1 roX2; [hsp83-roX1+])
were used. This design was adopted to minimize the genetic variation
between mutant and control.

* Organism (NCBI taxonomy)
Drosophila melanogaster

* Gender
Female

* Development stage
Third instar larvae

* Genetic variation (e.g., gene knockout, transgenic variation)
Transgenic variation

b) Hybridization extract preparation laboratory protocol for extract preparation,
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including: protocol description.
* Description:
Total RNA was prepared from groups of 50 third instar larvae by TRIzol
(Invitrogen) extraction and purified using the RNeasy kit (Qiagen).

* Extraction method
TRIzol standard protocol (Invitrogen), purification by RNeasy kit (Qiagen)

* Whether total RNA, mRNA, or genomic DNA is extracted
total RNA

* Amplification (RNA polymerases, PCR)
none

c) Labeling: laboratory protocol for labeling, including:
* Protocol
Standard protocols as described in the Affymetrix GeneChip® Expression
Analysis Technical Manual, P/N 702232, rev. 2, 2005-2006, Chapters 2-4.
cDNA synthesis was using the GeneChip® 3'-Amplification One-Cycle
cDNA Synthesis Kit (Affymetrix, #900431).
100% of cDNA product is used to synthesize biotin labeled cRNA by the
GeneChip® IVT Labeling Kit ( Affymetrix, #900449).
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* Amount of nucleic acids labeled
5 g total RNA was used for each samples

* Label used (e.g., Cy3, Cy5, 33P)
Biotin

4. Hybridizations: procedures and parameters
* Laboratory protocol for hybridization
Standard protocols as described in the Affymetrix GeneChip® Expression
Analysis Technical Manual, P/N 702232, rev. 2, 2005-2006, Chapter 3.

* Wash procedure
Wash protocol FS450_0002.

* Quantity of labeled target used
6.5 µg labeled cRNA

* Time, concentration, volume, temperature
Overnight (16h), 200 µl, at 45°C, rotating at 60 rpm

* Description of the hybridization instruments
GeneChip® Hybridization Oven 640 (Affymetrix, #800138)
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5. Measurements: images, quantitation, specifications:
a) Hybridization scan raw data:
a1) the scanner image file (e.g., TIFF) from the hybridized microarray scanning

a2) Scanning information:
Arrays were scanned by the Affymetrix GeneChip® Scanner 3000 with
Auto Loader (Affymetrix, #00-0090) expression analysis settings at "All
Probe Sets" Scale Factor 500, Normalization = 1.0, No Masking.

b) Image analysis and quantitation
The Chip Image was analyzed using GCOS 1.4 to produce a .CEL file of
probe intensities for each sample. The .CEL files were in turn modeled in
PM-MM mode to produce a spreadsheet of probeset intensities for all six
arrays.

The .CEL files and .CHP files were available in Gene Expression Omnibus
database (Access number: GSE12076).
Mutant_1: GSM304915
Mutant_2: GSM304916
Mutant_3: GSM304917
Control_1: GSM304918
Control_2: GSM304919
Control_3: GSM304920
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c) Annotation and alignment
All transcript alignments, Gene Names and Probeset IDs were extracted
from the Bioconductor annotation package “Affymetrix Drosophila Genome
2.0 Array Annotation Data (drosophila2)”. Transcripts were aligned to each
chromosome.

6. Normalization
Affymetrix Gene expression data was background corrected, normalized
and summarized into a one expression value per sample and probeset
using the RMA (robust multi-array average) algorithm. The Affymetrix
MAS5.0 Present/Absent calls were used to filter out the probesets that
were not present in at least 2 out of 3 samples in each group (mutant and
normal). All the probesets that could not be mapped to a known Entrez
Gene ID, according to the Bioconductor (www.bioconductor.org) drosophila
2 package, were removed from further analysis. The expression values
from multiple probes corresponding to the same Entrez Gene ID were
averaged together in each array (sample). The chromosome assignment of
each probeset was based on the drosophila 2 package in bioconductor.
The probes corresponding to genes situated in heterochromatin were
identified from the Fly database, assuming that all the remaining ones are
euchromatic genes. The log2 fold changes were computed as the mean
RMA expression values in the mutant sample minus the mean expression
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values in the control samples. The resulting log2 fold changes were then
compared among chromosomes using a Wilcoxon test. All the analyses
were performed using the R software environment (www.r-project.org) and
specialized bioconductor (www.bioconductor.org) software packages.
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APPENDIX B

A ROX1 TRANSGENE INSERTION REVEALS UNUSUAL FEMALE-SPECIFIC
LETHALITY

ABSTRACT
Integration of roX1R1-3 at a landing site within the X-linked Tao-1 gene
(18D3) was lethal. To obtain additional X-linked insertions of roX1R1, the
lethal roX1R1 integrant, as well as roX1R3 (as a control), was mobilized and
surviving

males

carrying

an

X-linked

w+

marker

were

identified.

Unexpectedly, most of these products of mobilization had strikingly
reduced viability of homozygous females. Genetic and molecular analysis
revealed that partial inserted sequences remaining in the original
integration site cause the female-specific lethality. X chromosomes
retaining different portions of the original inserted sequences complement
each other and rescue female survival. The insertion of different sequences
within this site may disturb Tao-1 transcript splicing. I postulated that
females are more sensitive to disruption in Tao-1 levels or splicing.

To investigate the function of 5’ roX1 sequence, three transgenes, roX1R1,
roX1R2 and roX1R3, were created in the pUASTB vector and inserted at 68A4 on
the third chromosome and at four sites on X chromosome (2A3, 16C1, 18D3 and
19C4) using the site-specific C31 integrase system. In this system,
recombination occurs between an attB site on the plasmid (pUASTB) containing
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the transgene and an attP site in the fly genome (Groth et al., 2004; Thorpe and
Smith, 1998). The transgenes were integrated into attP target sites, present in
the P[y+CaryattP] P-element, at different sites in the fly genome. Integration of
the pUASTB vector into P[y+CaryattP] created a complicated P element with two
3' ends and two 5' ends (Fig A-2). These are arranged in a manner that will
enable multiple modes of excision by transposase. While flies with transgenes
integrated at other sites show normal viability, integration of rox1R1-3 transgenes
at 18D3 is lethal in males and homozygous lethal in females. The 18D3 landing
site was created by mobilization of P[y+CaryattP] from 64A4 (obtained from
Bloomington Drosophila Stock Center) and selecting for insertions on X
chromosome. The exact location of 18D3 X-linked insertion was determined by
inverse PCR and sequencing (Inverse PCR Protocol available from Berkeley
Drosophila Genome Project; http://www.fruitfly.org/about/methods/inverse.pcr.
html). The landing site is located inside an intron of Tao-1, and, by itself, appears
to be fully viable (Figure A-1). Information from Flybase (www.flybase.org) shows
that this gene has 7 annotated transcripts, and 7 annotated polypeptides. The
putative product of Tao-1 is a serine/threonine kinase proposed to be involved in
apoptosis. Although 8 alleles are reported, there is no null allele available and no
phenotypic data available. There is also a MSL high affinity site located inside the
Tao-1 gene, which spans the insertion site (Figure A-1, (Straub et al., 2008)). It is
quite possible that Tao-1 is an essential gene and the disruption of Tao-1
function by insertion of transgenes causes lethality. However, insertion of
P[y+CaryattP] P-element at this site is viable, but intergration of a pUASTB
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Figure A-1. Annotation of the 18D3 insertion site and the MSL High Affinity
Site (HAS) located at this region. The blue arrow represents the Tao-1 gene.
Below are seven annotated Tao-1 transcripts. The exact insertion site of the attP
docking site is shown in relation to the Tao-1 gene and the MSL HAS (green line).
The annotation of Tao-1 gene is from FlyBase (www.flybase.org).
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Figure A-2. Structure of viable and lethal integrations at 18D3. The structure
of the viable insertion of pCaryP with attP landing site at 18D3 is shown in green.
Integrated pUASTB plasmids, carrying roX1 transgenes, are depicted in red.
Arrow direction represents the direction of gene transcription and the orientation
of att sequences. P-element ends are depicted by triangles. The sequence of
pCaryP and pUASTB are from (Groth et al., 2004).
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plasmid carrying roX1 transgenes into the attP site is lethal (Figure A-2). The
major difference of viable and lethal insertions at this site is the length of inserted
sequences. Insertion of 6.5 Kb P[y+CaryattP] P-element is viable, but pUASTB
integration increases the size to 17Kb. Longer insertion size, strong transcription
from the hsp83 promoter, or the recruitment of MSL proteins by roX1
transcription may disrupt Tao-1 expression. Alternatively, the strong expression of
roX1 transgene may interact with the MSL high affinity site and disrupt dosage
compensation of this region, which could be the reason for the lethality. However,
the latter mechanism is not favored because I found no genetic interactions
between the lethal insertion and MSL protein level.
My previous studies (Chapter 3) show that roX1R1 could not rescue roX1
roX2 males when transcribed from 16C1, but roX1R2 and roX1R3 could. To
investigate whether roX1R1 is toxic or non-functional when it comes from the X,
roX1R1 was mobilized from 18D3 to obtain viable insertions on the X and
autosomes. This was accomplished by introducing a transposase source (TMS,
sb P[ry+t7.2∆2-3]99B) and recovering males with the w+ marker. While no lethality
is observed for any autosomal reinsertion of the w+ marker, reinsertions on a
normal X chromosome show not only normal viability, but some reinsertions also
show female-specific lethality. For a control, roX1R3 was also mobilized, X and
autosomal insertions were collected. Surprisingly, roX1R3 showed the same result,
which suggested that the lethality is not due to roX1R1 toxicity.
The most confusing aspect of this result is the male viability and femalespecific lethality of X chromosomes produced by mobilization. In total nine X-
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linked lines were recovered (five for roX1R1, four for roX1R3) that are male viable
but female homozygous lethal. Homozygous females can develop into third instar
larva or pupae but die in the early pupae stage (data not shown). Female specific
lethality is rare in Drosophila. One possible reason is that the insertion interrupts
a gene required only in females. Another explanation is that the X-linked roX1
transgenes interact with a subset of MSL proteins locally to disrupt the female X
chromosome. To distinguish the two possibilities, female-specific lethal lines
were mated to test complementation. If transheterozygous females live, each
insertion disrupts a different female essential gene. If transheterozygous females
die, recruitment of MSL proteins by the transgenes is plausible. My
complementation result showed that the nine female-lethal chromosomes
produced by mobilization form two complementation groups. Group one contains
three lines (fl(1)18D3TW2B,R3, fl(1)18D3TW13B,R3 and fl(1)18D3TW14B,R3). Group two
contains six lines (fl(1)18D3TW5C,R3, fl(1)18D3TW27B,R3, fl(1)18D33,R3, fl(1)18D39,R3,
fl(1)18D311,R3 and fl(1)18D312,R3). A transheterozygous female with one X
chromosome from one group and one from the other group can survive. However,
a female with both X chromosomes from the same group is lethal. This made it
difficult to distinguish between mutation of a female-specific essential gene and
MSL recruitment as the source of lethality. To test recruitment of the MSL
proteins as the source of female lethality, I attempted to rescue females by
manipulation of MLE. Neither reducing MLE by half nor eliminating MLE rescued
homozygous females. Therefore, disruption of the female X chromosome by
recruitment of MSL proteins does not explain lethality. Next, I explored the
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possibility of interruption of genes required only in females. Inverse PCR and
sequencing was performed to determine the exact insertion sites in all femalespecific lethal lines. Unexpectedly, all lines retained P element sequences at the
original site within the Tao-1 intron. The gene causing female-specific lethality is
consequently suggested to be Tao-1 itself.
By molecular characterization of the remaining sequences in Tao-1, I
discovered that P element mobilization can occur multiple ways. There are
alternative combinations of 5' and 3' ends of P element that can excise the
inserted sequences (Figure A-3). Single fly PCR was performed to determine the
remaining sequences at this site in each line. As shown in figure A-3, all
members of a complementation group have excised the same way, leaving
identical residual transgene material in Tao-1. However, by some unexpected
mechanism, the excision to create group two removes material between two 5' P
element ends. I conclude that each of the two modes of excision that I
characterized produce male-viable and female-lethal alleles of Tao-1. In spite of
the female lethality of these two alleles, they complement one another for female
survival. It is likely that significant further effort will be required to determine the
molecular basis of female lethality and complementation.
Taken together, insertion of different sequences at the same site of Tao-1
intron displays different behaviors including full survival, lethal for both sexes and
female specific lethal. Insertion of the P[y+CaryattP] P element containing the
landing site at an intron of Tao-1 is viable (Figure A-4 A). Integration of pUASTB
containing roX1 transgenes into this landing site is lethal (Figure A-4 B). Reduction
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Figure A-3. Schematic illustration of insertions before and after
mobilization by transposase. (A) The [y+CaryattP] landing site at 18D3 after
integration of roX1 transgenes. Green depicts the original sequences of
[y+CaryattP], red is integrated pUASTB. (B) The remaining sequences at 18D3
after transposase mobilization from this site. In complementation group 1,
mobilization of 3' (green) and 5' (red) P element ends removes both yellow and
white. In complementation group 2, mobilization of 5' (red) and 5' (green) P
element ends removes the pUAST vector backbone and the roX1 transgene.
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Figure A-4. Summary of insertions that show different viabilities. (A) Flies
carrying only the landing site appear fully viable. (B) Flies with integration of any
of the roX1 transgenes are male and homozygous female lethal. (C) Flies with
either partial deletion of the transgene integration are male viable but
homozygous lethal in females. However, females are viable when they are
transheterozygous, carrying both partial deletions.
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of the inserted sequence by transposase-mediated mobilization produces two
different male viable but female lethal alleles of Tao-1 (Figure A-4 C). However,
females that are trans-heterozygous for these two alleles are viable. The most
plausible interpretation of my findings is that lethality is caused by disruption of
Tao-1 transcription or splicing. Females may be particularly sensitive to reduction
of Tao-1. My studies suggest that this sex-specific lethality is not related to
disruption of the X chromosome by roX1 expression or inappropriate dosage
compensation in females. To verify this conclusion, we ordered flies which carry
duplications of the region containing the Tao-1 gene on the third chromosome,
Dp(1;3)DC363 (duplicated region is 18C8-18D3, BDSC stock# 31453) and
Dp(1;3)DC364 (duplicated region is 18D1-18D13, BDSC stock# 32279), and
mated these flies to my lethal transgenes and excisions. As expected, the lethal
insertions of roX1R1, roX1R2 and roX1R3 at 18D3 are rescued by introducing a
copy of duplicated X region containing Tao-1 (Table A-1). All female-specific
lethal lines can also be rescued by the same duplications (Table A-2 and A-3).
In conclusion, our results suggest that Tao-1 is an essential gene.
Transcription or processing of Tao-1 may occur differently in males and females.
To future investigate Tao-1 and verify my findings, a Tao-1 deletion mutant could
be created and tested for viability. The sex-specific lethality of my excision lines
could be investigated by searching for alternative Tao-1 transcripts in males and
females by RT-PCR. Levels of Tao-1 transcripts in homozygous lethal and transheterozygous viable females could also be determined by Quantitative RT-PCR
to explore the mechanism of trans-heterozygous viability.
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Table A-1. Rescue of 18D3 lethal insertions by duplications of 18D3.
X chromosomes

Number of males that carry the lethal X chromosome

of lethal insertion

*DC363/+

+/+

[roX1R1]

13 (9)

[roX1R2]
[roX1R3]

#

DC364/+

+/+

0

22 (17)

0

5 (12)

0

34 (34)

0

14 (22)

0

22 (33)

0

[roX1R1-3] inserted at 18D3 is fully lethal. [roX1R1-3] / yw females were mated to
yw males that carry one copy of Dp(1;3)DC363 or Dp(1;3)DC364 on the third
chromosome. Only male offspring are recorded. The number of males carrying
the lethal integration is shown; the number of brothers carrying the yw
chromosome and the duplication is in parentheses.
*
DC363 (Dp(1;3)DC363) carries a duplication of 18C8–18D3 on the third
chromosome.
#
DC364 (Dp(1;3)DC364) carries a duplication of 18D1–18D13 on the third
chromosome.
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Table A-2. Rescue of female-specific lethal insertions by Dp(1;3) DC363.
Female-specific
lethal lines

*fl(1)18D3 / fl(1)18D3
#

DC363/+

+/+

fl(1)18D3 / +
DC363/+

+/+

fl(1)18D33,R3

18

0

11

20

fl(1)18D39,R3

22

0

21

22

fl(1)18D311,R3

13

0

16

13

fl(1)18D312,R3

13

0

15

20

fl(1)18D3TW14B,R1

21

0

20

17

fl(1)18D3TW27B,R1

19

0

17

14

fl(1)18D3TW2B,R1

29

0

30

27

fl(1)18D3TW5C,R1

25

0

18

22

Heterozygous females carrying a female-lethal X chromosome fl(1)18D3 were
mated to males with the same X chromosome and one copy of Dp(1;3)DC363 on
the third chromosome. The adults of the illustrated genotypes from each cross
were counted.
* the X chromosome genotype, fl(1)18D3 chromosome is the yw chromosome
with insertions of the leftover sequences at 18D3 after mobilization of P element
from this site.
#
the third chromosome genotype, DC363 is short for Dp(1;3)DC363, which
carries a duplication region of 18C8 – 18D3 on third chromosome. + means
wildtype.
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Table A-3. Rescue of female-specific lethal insertions by Dp(1;3) DC364.
Female-specific
lethal lines

*18D3 X / 18D3 X
#

DC364/+

+/+

18D3 X / yw
DC364/+

+/+

fl(1)18D33,R3

17

0

15

14

fl(1)18D39,R3

21

0

19

14

fl(1)18D311,R3

25

0

15

25

fl(1)18D312,R3

12

0

12

20

fl(1)18D3TW14B,R1

20

0

20

22

fl(1)18D3TW27B,R1

10

0

20

17

fl(1)18D3TW2B,R1

16

0

19

15

fl(1)18D3TW5C,R1

25

0

12

9

Heterozygous females carrying a female-lethal X chromosome fl(1)18D3 were
mated to males with the same X chromosome and one copy of Dp(1;3)DC363 on
the third chromosome. The adults of the illustrated genotypes from each cross
were counted.
* the X chromosome genotype, fl(1)18D3 chromosome is the yw chromosome
with insertions of the leftover sequences at 18D3 after mobilization of P element
from this site.
#
the third chromosome genotype, DC364 is short for Dp(1;3)DC364, which
carries a duplication region of 18C8 – 18D3 on third chromosome. + means
wildtype.
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APPENDIX C

JIL-1 ENRICHMENT ON THE X CHROMOSOME IS BLOCKED IN ROX1 ROX2
MALES

Two types of histone modifications are enriched on the male X
chromosome: H4K16 acetylation (Brownell and Allis, 1996) and histone H3S10
phosphorylation (Jin et al., 2000). The JIL-1 histone kinase is responsible for
phosphorylation of H3 on serine 10 during interphase. JIL-1 binds to chromatin
throughout the genome but is enriched on the male X chromosome (Jin et al.,
2000). JIL-1 is also suggested to be involved in dosage compensation. Proper
dosage compensation of the X-linked white gene requires normal JIL-1 function
(Lerach et al., 2005). However, JIL-1 does not appear to be a component of the
MSL complex (Mendjan et al., 2006; Smith et al., 2000). JIL-1 also plays a
general role in limiting heterochromatin spreading, and is essential in both sexes
(Ebert et al., 2004; Wang et al., 2001).
Simultaneous antibody staining of JIL-1 and MSL3 revealed that JIL-1
colocalized with MSL proteins on the male X chromosome (Figure A-5 A-C). The
X-specific binding of MSL is disrupted in roX1 roX2 males, which showed
deceased binding on X chromosome but a lot of ectopic binding on autosomal
sites (Figure A-5 E). JIL-1 enrichment on the X chromosome is also blocked
(Figure A-5 D). However, colocalization of JIL-1 and MSL3 occurred even in the
roX1 roX2 double mutant (Figure A-5 D-F). The colocalization of JIL-1 and MSL3
occurs at both X-linked and ectopic autosomal sites that are only observed in
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Figure A-5. JIL-1 is mislocalized in roX1 roX2 males. Antibodies against JIL-1
and MSL3 were applied simultaneously to polytene chromosome preparations.
JIL-1 is detected with FITC conjugated anti-rabbit, and MSL3 with TR conjugated
anti-goat antibodies. JIL-1 colocalizes with the MSL proteins to many sites in
roX1 roX2 double mutants. The full genotype of roX1 roX2 is roX1SMC17A Df(1)52;
[4Δ4.3].
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roX1 roX2 males (Figure A-5 F). This indicates that roX RNA influences JIL-1
localization. This might occur either directly, by interaction with the MSL complex,
or indirectly, for example, by recruitment by the H4K16ac modification that is
deposited by the MSL complex.
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roX1 FUNCTION IN DOSAGE COMPENSATION: STRUCTURAL /
FUNCTIONAL ANALYSIS OF A NON-CODING RNA
by
YING KONG
May 2012
Advisor: Dr. Victoria H. Meller
Major: Biological Sciences
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roX1 is a long non-coding RNA involved in the chromosome-wide gene
regulation that occurs during dosage compensation in Drosophila. Dosage
compensation in Drosophila melanogaster occurs by a global two-fold increase of
transcription from the single male X chromosome. This essential process
compensates for X chromosome monosomy. The male-specific lethal (MSL)
complex, containing five proteins, localizes to the male X chromosome and alters
chromatin to modify gene expression. roX1 and roX2 RNAs are redundant
components of MSL complex that are required for its exclusive X-localization.
Recent studies in our lab have revealed a second role of roX RNAs in
heterochromatic gene expression in males. The roX-dependent heterochromatic
regulation system involves some, but not all, MSL proteins. Although all
components of this system discovered now are expressed in females, microarray
analysis showed that the roX1 RNA has no detectable affect on expression of
both X-linked and heterochromatic genes in females. Therefore, like dosage
compensation, the roX-dependent heterochromatic regulation system is also
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limited to males. The differential regulation of heterochromatic genes in males
and females may reflect the differences of heterochromatin between them.
Previous studies of roX1 mutants and transgenes have identified a large region
at the 5’ end of roX1 that is necessary for X-localization of the MSL complex. To
dissect the function of this region, roX1 transgenes containing portions of the 5’
end were generated and analyzed. Multiple redundant elements contributing to X
chromosome targeting were found to be present throughout the 5’ end of roX1.
These roX1 transgenes display different stability, but all can partially restore Xlinked gene expression in a roX1 roX2 mutant. One portion of this region is
uniquely able to promote MSL complex spreading from sites of transcription.
Previous model of MSL spreading suggested a verse relevance of roX1 transcript
abundance and the ability to spread. However, the ability of this region to direct
MSL spreading is not relevant to its abundance. The activities I have detected
are hypothesized to be regulated by choice of transcription start site, alternative
splicing and/or transcript stability.
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